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Be the Best of Whatever You Are - (2009)      
 
 
If you can't be a pine on the top of the hill, 
Be a scrub in the valley, but be 
The best little scrub by the side of the rill; 
Be a bush if you can't be a tree. 
 
If you can't be a bush be a bit of the grass, 
And some highway happier make; 
If you can't be a muskie then just be a bass  
But the liveliest bass in the lake! 
 
We can't all be captains, we've got to be crew, 
There's something for all of us here, 
There's big work to do, and there's lesser to do, 
And the task you must do is the near. 
 
If you can't be a highway then just be a trail, 
If you can't be the sun be a star; 
It isn't by size that you win or you fail  
Be the best of whatever you are! 
 
Douglas Malloch 
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Abstract 
Breast adenocarcinoma is one of the major causes of death among women 
worldwide (the second most lethal cancer type in Portugal) and can be caused by oxidative 
stress conditions. The development of chemopreventive agents against this type of 
neoplasia is therefore of the utmost importance, in order to reduce the risk of this type of 
oxidative stress-related diseases. 
Phytochemicals (such as hydroxycinnamic acids and isoflavones) are an abundant 
source of antioxidants present in our daily diet known to significantly decrease the 
harmful effect due to oxidative species, and therefore being promising chemopreventive 
agents towards carcinogenesis. 
The present work aims at assessing two dietary antioxidants – p-coumaric acid (p-
Ca, a monohydroxylated phenolic acid) and daidzein (DA, an isoflavone) – as potential 
chemopreventive agents, using as biological models the human breast cancer cell lines 
MCF-7 (estrogen-dependent) and MDA-MB-231 (estrogen-independent). A 
multidisciplinary approach was followed, coupling biological assays to cutting-edge 
vibrational spectroscopy techniques, to evaluate (for distinct concentrations, at 48 h 
exposure time): (i) cell proliferation/viability, by the SRB and MTT colorimetric tests; (ii) 
antimetastatic ability, using a transwell invasion chamber; (iii) generation of ROS/RNS 
species, through a fluorimetric technique (2ʹ,7ʹ-dichlorofluorescin diacetate probe); (iv) 
metabolic impact at the cellular level via Raman microspectroscopy of fixed cells. 
MicroRaman of cell cultures, in particular, allows an accurate and non-invasive probing of 
biospecimens, constituting an invaluable and innovative method for monitoring the effect 
of an external agent on the intracellular biochemical profile. 
At both 50 and 100 μM, p-Ca was found to induce a significant increase in cell 
viability for MDA-MB-231, although the Raman data did not show a clear differentiation 
between the control and the treated cells. In contrast, at 7.5 and 15 μM p-Ca induced a 
slight viability decrease, the Raman spectra having reflected changes in the cellular 
chemical composition (mostly in lipids and proteins). For the MCF-7 cells, p-Ca did not 
show any significant effect (in the whole concentration range tested) through either 
biological assays or Raman microspectroscopy. The ROS/RNS measurements 
corroborated these conclusions, and evidenced a striking cell-selectivity for both 
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polyphenols studied. 
Regarding daidzein, a 100 μM dosage led to a marked decrease in cell viability (ca. 
50%) for the MDA-MB-231 line, the Raman data evidencing differences in the lipid and 
protein content. For the MCF-7 cells, viability was found to decrease considerably (30% to 
40%) for 50 and 100 μM concentrations, which was corroborated by microRaman. 
In conclusion, the results gathered for 50 and 100 μM p-Ca allow us to hypothesise 
on a pro-oxidant effect of the phenolic acid on this type of cancer cells (mainly for the 
highest concentration tested), the increased intracellular levels of ROS leading to an 
enhanced neoplastic proliferation (which is known to be associated with a need for ROS). 
At low concentrations, the compounds appear to affect mostly lipids which could be a 
promising chemoprotective strategy towards ROS-induced lipid damage associated to 
carcinogenesis. DA, in particular, was shown to be a promising chemoprotective agent 
against hormone-dependent breast adenocarcinoma. In addition, both dietary 
polyphenols can be envisaged as potential agents in adjuvant therapy for non-hormone 
dependent breast cancer. 
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Resumo 
O cancro de mama é atualmente uma das principais causas de morte entre as 
mulheres em todo o mundo (e o segundo tipo de cancro mais mortal em Portugal), 
podendo ser provocado por condições de stresse oxidativo. O desenvolvimento de 
agentes quimiopreventivos contra este tipo de neoplasia é assim da maior relevância, com 
vista a reduzir a incidência desta patologia induzida por stresse oxidativo. 
Os compostos fitoquímicos (como os ácidos hidroxicinâmicos e as isoflavonas) são 
uma importante fonte de antioxidantes presentes na dieta. São responsáveis por uma 
diminuição considerável dos efeitos nocivos de espécies oxidantes no nosso organismo, 
constituindo assim um grupo promissor de potenciais agentes quimiopreventivos face a 
processos carcinogénicos. 
O objectivo deste trabalho é o estudo de dois antioxidantes da dieta – ácido p-
coumárico (p-Ca, um ácido fenólico monohidroxilado) e daidzeína (DA, uma isoflavona) – 
como potenciais agentes quimiopreventivos, utilizando como modelo biológico as linhas 
celulares humanas da cancro de mama MCF-7 (dependente de estrogénio) e MDA-MB-
231 (independente de estrogénio). Foi seguida uma estratégia multidisciplinar, que 
combinou ensaios biológicos com técnicas de ponta de espectroscopia vibracional, para 
avaliar (a distintas concentrações e para um tempo de exposição aos compostos de 48 h): 
(i) a proliferação celular/viabilidade, através dos testes colorimétricos de SRB e MTT; (ii) 
a capacidade antimetastática, usando uma câmara de invasão “transwell”; (iii) a formação 
de espécies ROS/RNS, mediante uma técnica fluorimétrica (com a sonda 2ʹ,7ʹ-
diclorofluoresceína diacetato); (iv) o impacto metabólico ao nível celular via 
microespectroscopia de Raman em células fixas. Em particular, a técnica de microRaman 
aplicada a culturas celulares permite uma monitorização rigorosa e não invasiva de 
amostras biológicas, constituindo uma ferramenta preciosa e inovadora para a avaliação 
do efeito de agentes externos no perfil bioquímico intracelular. 
Para as concentrações de 50 e 100 μM, o p-Ca demonstra ter capacidade de 
aumentar significativamente a viabilidade celular para MDA-MB-231, porém os resultados 
de Raman não mostram nenhuma diferenciação entre o controlo e as células tratadas. Em 
contraste, as concentrações de 7.5 e 15 μM de p-Ca induzem uma pequena diminuição da 
viabilidade, porém os espectro de Raman exibem modificações a nível da composição 
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química (maioritariamenta lípidos e proteínas). Para as MCF-7, o p-Ca não demonstrou 
ter qualquer efeito significativo (em todos os intrevalos de concentrações) quer nos 
ensaios biológicos como para microscopia de Raman.  
As medições de ROS/RNS concordam com estas conclusões, e evidenciam a 
seletividade demostrada pelos polifenóis em estudo. 
Para a daidzeina, a concentração de 100 μM de daidzeina reduz a viabilidade celular 
(aproximadamente 50%) para a linha celular MDA-MB-231, os resultados de Raman 
evidenciam diferenças nos lípidos e no conteúdo proteíco. Para as MCF-7, a viabilidade é 
reduzida (30% e 40%) para 50 e 100 μM, confirmado por microRaman 
Em conclusão, os resultados obtidos para 50 e 100 μM p-Ca permitem hipotetizar 
sobre o efeito pro-oxidante do ácido fenólico neste tipo de células (dando enfase às 
concentrações mais elevadas), o aumento dos níveis intracelulares de ROS levam ao 
aumento da proliferação neoplasica (que se sabe estar associada à necessidade de ROS). 
Em concentrações mais baixas, os compostos demonstram interagir com os 
lípidos, podendo vir a ser uma promissora estratégia quimiopreventiva para 
carcinogéneses induzidas por alterações nos lípidos provocadas por ROS. 
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DA Daidzein 
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MAPKs Mitogen-activated protein kinase 
MgF2 Magnesium fluoride 
MMP Metalloproteinases family 
MnSOD Manganese superoxide dismutase
MTT 3-(4,5-dimethylthiazol-2-2yl)-2,5-diphenyl tetrazolium bromide 
myc Gene of transcription factor 
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NA Numerical aperture 
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
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  Out of plane deformation vibration 
FT-Raman Fourier transform Raman spectroscopy 
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1.1. Free Radicals, Oxidative Stress and Disease 
1.1.1. Free Radical Species 
In the 1950´s, free radicals (reactive oxygen, nitrogen and sulphur species – ROS, 
RNS and RSS) were identified in biological systems and were proposed to be involved in 
diverse pathological processes [1]. Previously, Denham Harman had proposed that free 
radicals might have an active role in the aging process [2]. Over the years, the interest and 
research efforts on free radicals’ effect on biologic systems, including their role in 
oxidative-related disorders, has grown and is currently an active field of study with a 
recognized impact on human health. 
A free radical is defined as a species capable of independent existence [3] that 
contains one or more unpaired electrons in the outer electron shell [3-8], which is 
responsible for a high reactivity [5]. Two free radicals can join their unpaired electrons to 
form a covalent bond [3] or can bind with electrons of neighbouring species giving rise to 
a chain reaction [6,9] and finally yielding a new free radical. This chain reaction can modify 
the structure and/or function of molecules, interfering with the normal biochemical 
processes within the cell. Therefore, organisms need an antioxidant defensive system [10] 
(Section 3). 
There is a diversity of free radicals, namely oxygen and nitrogen reactive species 
(ROS and RNS, respectively, Table 1) [4,6,8,10]. The former include superoxide anion, 
hydroxyl, peroxyl, lipid peroxyl, alkoxyl radicals and hydrogen peroxide (which is not a free 
radical but is chemically very reactive, being involved in the production of other free 
radicals) [4,6,8,10,11]. RNS encompasses nitrogen dioxide [4,8] and nitric oxide [1,4,8,10], 
peroxynitrite (ONOO-) and nitrite (NO2-) that are produced by a family of enzymes (nitric 
oxide synthases, NOSs [9,11] very important in a variety of intracellular signalling 
processes (e.g. neurotransmission) and in the relaxation of smooth muscle [10]. In 
addition, ROS and RNS comprise non-radical species that can also lead to free radical 
reactions in living organism [8]. 
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Table 1 – Most relevant oxygen (ROS) and nitrogen (RNS) free radicals in living organisms. 
Free radicals 
ROS Ref Biological 
effect  
RNS Ref Biological effect  
superoxide 
anion (O2•−) 
[3,4,6,8,10,
11] 
Lipid, 
proteins and 
DNA 
oxidation 
nitric oxide 
(NO•)  
[1,4,8,10] Neurotransmitter
s and relaxation 
of smooth muscle 
 
 
hydroxyl (•OH) [3,4,6,8,10,
11] 
Damage in 
specific 
targets 
(guanine, 
histidine, 
tryptophan 
and tyrosine) 
nitrogen 
dioxide 
(NO2•) 
[4,8,12]  
peroxyl (ROO•) 
including lipid 
peroxyl (LOO•) 
[3,4,6,8,10,
11] 
lipid 
peroxidation 
nitrite 
(NO3•) 
[9,12]  
alkoxyl (RO•) [3,4,6,8,10,
11] 
    
hydrogen 
peroxide (H2O2) 
[4,6,8,10,11
,13] 
DNA damage     
 
Oxygen and nitrogen reactive species are produced in animals and humans under 
both physiologic and pathologic conditions [8,10], and have an important role in living 
organisms [5], their effect being strongly dependent on concentration. As an example, 
ROS induces cell growth and proliferation at nanomolecular levels [13,14], cause transient 
growth arrest and protective adaptive alterations in gene expression at micromolar levels 
and lead to oxidative stress at milimolar concentrations [13]  having even been found to 
trigger signalling pathways which arrest cell proliferation at high dosages [14,15].  
Although human life depends on oxygen for several crucial pathways, it is also a 
source of free radicals: in aerobic respiration, 80% of O2 consumed [9] is used to generate 
energy in mitochondria [16], and 1-5% is transformed into superoxide and hydroxyl 
radicals [9,15,17]. Biological systems are therefore exposed to free radicals produced via 
endogenous and exogenous pathways [8,9,18,19]. 
1. Biological Systems 
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1.1.1.1. Endogenous Sources of Free Radicals 
Endogenous production of ROS is essential for regulating physiological functions in 
healthy cells (e.g. metabolic processes and cellular signalling, [5,6,8-10,16,20,21] (Figure 
1). During inflammation, a cellular signal process, for instance, free radicals such as O2• − 
and H2O2 are generated by the immune system [6,8-10,15,19,22], when neutrophils and 
macrophages increase oxygen consumption). Phagocytes also produce ROS [21], in order 
to destroy invading pathogens and modulate the inflammatory response [19,22].  
Numerous pathways can be activated in response to low levels of ROS, such as the 
epidermal growth factor receptor (EGFR) pathway [11]. Additionally, metabolic processes 
include some the activity of enzymes and metal ions (e.g. Cu2+, Fe3+) which also sources of 
free radicals in cells, as well as mental and body stress [21], conditions such as ischemia 
and an excessive physical activity are also endogenous sources of ROS [15]. 
 
Figure 1 – Endogenous sources of ROS and RNS. 
En
do
ge
no
us
 so
ur
ce
 o
f R
O
S
Metabolic Processes 
[6,8,10,20]
Enzymes
Metal Ions [21]
Mitochondria 
respiration [8,19,21]
Stress [8]
Mental [8]
Body [8]
Cellular Signalling
[10]
Immune response 
[6,8,11,15]
Phagocytes [21]
Neutrophiles [10,15]
Macrophages [10,15]Signal transduction [5,6,10,16,21]
Enzyme activation 
[5,6,10,16,21]
Gene expression 
[5,6,10,16,21]
Protein synthesis 
[5,6,9,16,21]
Other factors
Ischemia
Excess pf physical 
exercises
Paula Sofia Coutinho Medeiros 
18 
 
1.1.1.2 Exogenous Sources of Free Radicals 
External sources of free radicals include xenobiotics [11,19], pollution (air and water 
pollutants), chemical solvents and external radiation (e.g. UV-B, [8,11,15,18,19,21,23]) 
(Figure 2). Exposure to these deleterious species is responsible for an increased level of 
free radicals, which may lead to oxidative stress related diseases [15]. Tobacco smoke is 
one of the main sources of free radicals, due to oxidative compounds present in smoke 
[11,15,21]. Furthermore, alcohol and drug consumption [8,11,18], wrong dietary habits 
or certain therapeutic schemes may also promote free radical production [15,19]. 
 
Figure 2 – Exogenous sources of ROS and RNS. 
1.1.2. Oxidative Stress-Induced Diseases 
Living organisms have specific mechanisms for keeping low intracellular ROS/RNS 
levels [1], e.g. a strictly regulated equilibrium between radicals´ production and 
elimination processes, leading to a steady-state (homeostasis) [1,9], thus avoiding 
oxidative damage due to non-controlled ROS/RNS formation [9]. Under physiological 
conditions, it has been estimated that a human cell is exposed to ca. 1x104 to 1x105 
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oxidative lesions per day [9,10,19], that are dependent on a variety of factors, namely 
environment, pollution, metabolism, diet, lifestyle and age [13]. 
The endogenous antioxidant system counteracts the harmful effects of free radicals, 
aiming to maintain a homeostatic state. However, under some conditions the equilibrium 
between free radicals and antioxidant production is lost [6,10] and the cell´s antioxidant 
defences are unable to overcome the oxidative attack and fail to repair their consequent 
damage, leading to a physiologic condition known as oxidative stress [1,6,10,11,24]: a 
serious imbalance between free radical production and antioxidant defences (Figure 3) 
[22]. 
 
Figure 3 – Schematic representation of oxidative stress conditions. 
This can be due to a variety of reasons: a) endogenous and exogenous 
overproduction of ROS [1,6,8,11]; b) insufficient antioxidant defence mechanisms 
[6,11,22], by depletion or/and decrease of antioxidant production [1,8,22]; c) a 
combination of these two factors. A similar condition may occur regarding reactive 
nitrogen species and is referred as nitrosative stress [8]. 
Oxidative (and/or nitrosative) stress accumulation over time contributes to the 
development of several severe diseases [25], such as cardiovascular and 
neurodegenerative disorders and cancer [24]. NO• expression affects tumour 
development, may inhibit or promote, according to cell setting and concentration. Their 
promotion role is related to DNA damage and stimulation of vascular endothelial growth 
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factor (VEGF) which promotes angiogenesis, contributing to tumour growth and cell 
invasion [9]. 
Typically, the majority of ROS have a short half-life and cause damage only locally, 
but some of these species, namely H2O2, have a relatively long half-life and can diffuse 
through quite long distances within the organism causing DNA damage at distant sites 
from its origin [1]. The •OH, in turn, is a lower-energy singlet molecular oxygen and can 
produce a massive damage through particular targets (guanine, histidine, tryptophan, and 
tyrosine) reacting with both DNA and proteins [1,9,12] and being implicated in 
mutagenesis, carcinogenesis and aging processes [12,15]. In contrast, O2•− is completely 
unreactive towards biomolecules [1]. Additionally, RNS appear to contribute to 
cardiovascular disease, since peroxynitrite (generated by reaction of NO with O2•− in 
vascular endothelium), leads to proinflammatory cytokine-mediated myocardial 
dysfunction [26]. 
Hence, the presence of an excessive concentration of free radicals constitutes a 
serious risk for normal cellular function, especially when mediated by changes in 
biomolecules such as nucleic acids, proteins, polysaccharides and lipids, that are 
preferentially affected by oxygenated free radicals [1,6,9-11,24]. Table 2 comprises the 
main cellular targets of oxidative stress and the most significant physiologic 
consequences. 
Oxidative DNA damage is one of the most severe consequences of oxidative stress 
conditions [19], since injured DNA has the potential to induce mutations [6,27]. Therefore, 
DNA damage needs to be properly addressed and repaired by endogenous mechanisms, 
prior to or during replication, with a view to prevent replication errors, genomic 
instability, cell death, or impairment of transcription and signalling pathways, all of which 
have been associated to carcinogenesis [19,28]. 
Free radicals can interfere directly with proteins, or can interact with sugars and 
lipids yielding products that then react with proteins [19]. Oxidative protein damage can 
induce several alterations, from fragmentation and/or aggregation to an enhanced 
susceptibility to proteolysis leading to oxidation and degradation [6,10]. This may impair 
protein function [6,10,16] and enzymatic activity [9]. Reactive oxygen/nitrogen species 
can also induce conformational changes in protein receptors, thus affecting cellular 
signalling mechanisms [19].  
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Table 2 – Main cellular targets of oxidative stress and physiological impact. 
Target Ref Consequence Ref 
DNA [21,29]  Mutation gene sequence; oxidized purines and 
pyrimidines; single- and double-strand breaks;  
[6,19,28,29] 
RNA [19] Modification of bases; ribose and strand break [19] 
Proteins [13,21] loss of sulfhydryl groups; amino acid 
modification; 
 
Fragmentation and aggregation; susceptibility 
to proteolysis; degradation and structural 
alterations; 
 
inhibition of normal cellular functions; cell 
death (apoptosis or necrosis) 
[13] 
Enzymes [21] inhibition of enzymatic activity [13] 
Lipids  Lipid peroxidation; alteration of membrane 
fluidity and permeability  
[15] 
Polyunsaturat
ed fatty acids 
(PUFA) 
[19] unstable membrane structure; altered 
membrane fluidity and permeability; impaired 
signal transduction 
 
 
Lipids are the most susceptible biomolecules to ROS/RNS injury, membranes of cells 
and organelles being very prone to damage (especially those with polyunsaturated fatty 
acids (PUFA), [6,9,10,16] either via direct interaction with free radicals or by formation of 
peroxides and their breakdown products [21]. This results in unstable membrane 
structures and altered membrane fluidity and permeability [6,16], also affecting signal 
transduction [6]. 
Moreover, oxidative stress has been associated with neuronal death [30], through 
mitochondrial damage, when proteasome pathway are inhibited (oxidation and nitrate 
inactivation of proteasome subunits) - ubiquitin-proteasome system is needed to 
development and maintenance of neurons and have a role in axonal degeneration after 
nerve injury [12]-, or via dopamine oxidation. 
Some studies have demonstrated that free radicals activate neoplastic 
transformation by diverse mechanisms [10]: inactivation of expression of oncogenes (e.g. 
Ras, myc, telomerase) and suppressor genes (p53, p21, PTEN) [10,11], or increased 
expression of proto-oncogenes [31]. These transformations can lead to the induction of 
cell damage [10], senescence or escape from apoptosis [11]. ROS is also associated with 
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hypoxia, which is a condition reported in almost every tumours, which is an oxygen 
diffusion limitation in primary tumours or their metastasis [14]. Hypoxia leads to an 
increase of mitochondrial ROS [14] causing oxidative stress which activate 
metalloproteinases (MMP) [31,32]- a family of collagenase that aids vessel growth [31]– 
which are  associated with increasing tumour vessel supply promoting angiogenesis, cell 
invasion as well as metastasis [31,32]. 
In summary, oxidative damage plays a pivotal role in a wide variety of human 
diseases: besides cancer and cardiovascular or neurodegenerative disorders, it can cause 
rheumatoid arthritis, muscular dystrophy, diabetes, among others [1,16,17,24,32,33] 
(Table 3). 
Table 3 – Main oxidative stress-induced human pathologies. 
Diseases Oxidative Damage Related Ref 
Cancer [1,16,17,22,25] 
Diabetes mellitus type 2 [1,16,17,34]  
Cardiovascular diseases [1,16,17,34] 
Neurodegenerative diseases [1,12,16,17,25,34] 
Parkinson's [19] 
Alzheimer's [19,25] 
Cataract formation [1,16,17,34] 
Aging [1,3,16,17] 
Rheumatoid arthritis [1,16,17,34] 
Acute respiratory distress syndrome [1,16,17] 
Asthma [1,16,17] 
Obesity [1,16,17] 
Hepatitis C [19] 
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1.2. Breast Cancer 
Cancer is becoming the major cause of morbidity and mortality worldwide [35], and 
is estimated that in the next decades it will affect every region of the world, closely 
following cardiovascular disorders [36]. Cancer results from a deregulated cell 
proliferation caused by DNA mutations, induced by a carcinogenesis process. This may be 
due to a variety of carcinogenic agents: chemical (drugs and chemical pollutants); 
biological (viruses), or physical (radiation) [35]. 
Among cancers, breast cancer is an important public health problem as it is the 
second most lethal cancer among women worldwide [37,38]: according to the World 
Health Organisation (WHO), it affects 28% of the women in Europe [39]. In Portugal, the 
woman death rate attributed to breast cancer has been growing steadily, 30.3% deaths in 
2010 [40]. Despite being associated with women, breast cancer can also affected men. 
The major risks of developing breast cancer are age [35,36,41] , early menarche, delayed 
menopause, use of contraceptives, hormone therapy, genetic predisposition and obesity 
[35]. Women over 50 years old are the most affected, with a 79% incidence (in United 
Sates of America, 2006-2010) and metastasis remains a significant cause of mortality [42]. 
There are two models proposed for carcinogenesis regarding breast carcinoma: a) DNA 
mutation and b) induced by steroid hormones. 
Epidemiological evidence has demonstrated a clear difference in breast cancer incidence 
between Eastern and Western countries [37,41,42], Asian women being the least affected 
[41,42] which can be related to diet. Additionally, a large number of epidemiologic studies 
support a diet rich in vegetables and fruits as an effective chemopreventive strategy 
towards this type of cancer [37]. 
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1.2.1 Oxidative Stress-Induced Breast Cancer 
Carcinogenesis is a multi-step process, comprising initiation, promotion and 
progression [19] (Figure 4). 
 
Figure 4 – Cancer progression. (Adapted from [43]) 
Initiation takes place when a normal cell undergoes DNA damage (due to ROS/RNS) 
and proceeds via DNA synthesis, resulting in the fixation of the mutation, thus yielding an 
initiated cell [19,44]. The promotion process involves modulation of gene expression 
resulting in an increased cell division and/or decreased apoptotic cell death, leading to a 
continuous cell proliferation that may induce subsequent mutations in these 
preneoplastic cells, resulting in a neoplasm [19]. Progression, the last step of the process, 
involves additional damage to the genome and, unlike the promotion step, is irreversible 
[19]. 
Epidemiologic data have shown that chronic oxidative stress is strongly related with 
carcinogenesis [10,11,19,29,38] , ROS/RNS species being present at higher concentrations 
in cancer cells (relative to non-neoplastic ones) [19,29,35]. Actually, the role of free 
radicals in breast cancer development may not be limited to early mutations, but probably 
affects all phases [31], including angiogenesis and metastasis [10,16,22,28]. Upregulated 
levels of free radicals in breast cancer that may cause DNA damage along with defective 
DNA repair mechanisms when compared to normal breast tissue [10,38]. 
Numerous factors and different pathways are responsible for an increased level of 
reactive oxygen species in breast tumour tissue [35], the most important of which will be 
described in this section. Telomere genes are highly susceptible to mutation in the 
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presence of free radicals [27] and it is apparent that suppressor genes such as p53 are 
affected by oxidative stress [10,14,27,35]. This gene activates several pathways involved 
in programmed cell death [35], regulation of the expression of gene code antioxidant 
proteins and prevention of oncogenic transformation [10,14,35]. ROS-related p53 
mutations or p53 loss have been detected in over 50% of human cancers and are 
associated with aggressive tumour growth [14]. p53 is dose-regulated by free radicals 
[10,35]: under physiological conditions free radicals´ concentration is low and p53 
expression is moderated; when the level of free radicals increases p53 is stimulated, 
promoting oxidative stress and the consequent DNA damage and cellular apoptotic death. 
Another effect of a high concentration of ROS/RNS is p53 inactivation by direct DNA 
damage [10]. 
In addition, persistent inflammation proceeds a variety of cancers, including breast 
cancer, and involves an immune response (namely through macrophages and neutrophils) 
[35]. Sublethal oxidative stress promotes cell proliferation in vitro by stimulation of 
superoxide and hydrogen peroxide, which activates MAPKs (mitogen-activated protein 
kinase) pathways [31]. MAPKs play a role in cell growth and cancer under conditions of 
oxidative stress [35].  Since oxidative stress may induce apoptosis, some therapeutic 
schemes that lead to the production of ROS in carcinoma cells are used in the clinic: 
certain drugs (e.g. doxorubicin, mitomycin C, tamoxifen) [31,45], photodynamic therapy 
or radiotherapy. Regarding breast cancer, tamoxifen, a well-known antioestrogen agent, 
is known to induce oxidative stress in vitro [31,45]. 
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1.3. Antioxidant Defences 
Upon exposure to oxidants (or oxidative stress-inducing agents), mammalian cells 
express stress-induced genes, which encode the antioxidant defence mechanism to 
metabolize these reactive species into nonreactive ones [19] , thus reducing (or hindering) 
their harmful effect. Halliwell and Gutteridge defined antioxidant “as any substance that, 
when at low concentration compared to those of an oxidisable substrate, significantly 
delays or prevents oxidation of that substrate” [3,8,46]. Indeed, this is the first line of 
cellular defence against free radicals [9,47]. 
Antioxidant defences depend on both the endogenous [8,15,47] production of 
antioxidant compounds and the dietary intake of antioxidant food products (exogenous, 
mostly phytochemicals) [8,15,47]. These molecules counterbalance the deleterious effect 
of free radicals [8,46,47] by: a) catalysing a complex cascade of reactions that convert 
ROS/RNS into stable entities like water and O2; b) through direct scavenging of the radical 
species [47], thus neutralizing them and maintaining the body´s redox balance [8,35]. An 
antioxidant compound is classified according to their biochemical mechanism of action 
[15,30] ( 
Table 4). 
Table 4 – Main antioxidant defences in mammalian cells. 
Antioxidant enzymes 
Antioxidant 
Species 
Forms 
present in 
body 
Location Source Function Ref 
Superoxide dismutase 
(SOD]  
Endogenous 
production 
catalyses the 
dismutation 
of O2•− to 
H2O2 
[6,9,15,30,
46,47] 
 
SOD1 Mitochondria, cytoplasm 
Endogenous 
production  
[8,15,46] 
SOD2 
(Manganes
e 
superoxide 
dismutase ] 
Mitochondria, 
cytoplasm, 
lysosome 
Endogenous
production  
[8,15,46] 
SOD3 Extracellular Endogenous production  
[8,15] 
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Catalase (CAT] Common in cell Endogenous production  
[6,8,9,15,3
0,46] 
Glutathione peroxidase 
(GPx] Cytoplasm 
Endogenous 
production 
Reduction of 
H2O2 
[6,9,15,35,
47] 
 
GPx1 Cytosol Endogenous production  
[15,48] 
GPx2 Intestinal epithelium 
Endogenous 
production  
[15,48] 
GPx3 Plasma Endogenous production  
[15,48] 
Gpx4  Endogenous production 
Protection of 
membranes 
[15,48] 
GPx8 
(mammalia
n 
glutathione 
peroxidase] 
Membrane 
protein of the 
endoplasmic 
reticulum 
Endogenous 
production 
 
 [15,48] 
Peroxiredoxin  Endogenous production  
[15] 
Chain-Breaking Antioxidants 
Antioxidant 
Form(s] 
present in 
body 
Biodistribution Source Function Ref 
Glutathione (GSH]  Endogenous production  
[6,9,15,35,
47] 
 
Reductase 
form 
(Glutathion
e 
reductase] 
(GR] 
Cytosol, nuclei 
and 
mitochondria 
Endogenous 
production 
sequestrates 
of ROS which 
are 
transformed 
and recycled 
[9] 
[6,8,9] 
 
Oxidized 
form 
(Glutathion
e disulphide 
(GSSG]] 
Endogenous 
production  
[6,8,9] 
Peroxidases Cytosol, mithocondria 
Endogenous 
production  
[15,49] 
Thioredoxin  Endogenous production  
[15,35,47] 
Uric acid  Endogenous production  
[6,15,35] 
Lipoic acid  Endogenous production  
[6,8] 
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reduced 
form 
(dihydrolipo
ic acid] 
 Endogenous production  
[8] 
Vitamin C (ascorbic acid] 
cytosol, plasma 
and other body 
fluids 
Dietary 
source 
protection of 
endogenous 
DNA damage; 
lipid 
peroxidation; 
reduction of 
pro-oxidant 
effect of 
tocopherol 
radical [48] 
[6,15,35,4
6] 
Vitamin D  Dietary source  
[47] 
Vitamin E 
family of 
fat-soluble 
compounds 
low-density 
lipoproteins 
(LDL] 
Dietary 
source  
[6,35,46] 
Beta-
carotene 
Vitamin A 
precursor  
Dietary 
source  
[46] 
Vitamin A fat-soluble compounds  
Dietary 
source  
[35,46] 
 
1.3.1. Antioxidant enzymes 
Antioxidant enzymes include catalase (CAT), peroxidases and superoxide dismutase 
(SOD) which is probably the most important one in the cell [15]. SOD catalyses the 
neutralization of the superoxide radical-induced damage [8,30,46] by converting it to 
hydrogen peroxide (H2O2) [8,15] and O2 [8,30]. This reaction is the body’s primary 
antioxidant defence, preventing further generation of free radicals [30]. Humans have 
three forms of superoxide dismutase: SOD1 is found in mitochondria as well as the 
cytosol, [8,15] and requires both copper and zinc for its function [15]; SOD2 only occurs 
in mitochondria [8,15]; SOD 3 is found in the extracellular media [8,15] and requires 
copper-zinc as cofactor [15]. 
Catalase is an enzyme widely distributed in cells that converts hydrogen peroxide 
into water and oxygen in cells [8,15,30], completely neutralizing the superoxide free 
radical [15,30]. CAT requires iron as a cofactor, which is attach to active site [15]. 
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The glutathione peroxidases (GPx) comprise eight distinct enzymatic forms (GP1x to 
GP8x) [15], which prevent the formation of hydroxyl radicals from H2O2 and protect the 
cell against H2O2-induced oxidative injury [8]. GPx1 to GPx4 and GPx6 (selenium-
containing enzymes) and GPx5, GPx7 and GPx8 (non-selenium) have an important role in 
detoxifying the cell from hydroperoxides. GPx1 can interact with hydrogen peroxide and 
soluble low-molecular-weight hydroperoxides, being involved in the prevention of cancer 
and neurodegenerative diseases. GPx3 is suggested to regulate the bioavailability of nitric 
oxide produced from platelets and vascular cells. GPx4, in turn, reduces hydroperoxides 
in membrane lipids and lipoproteins [50]. 
Peroxiredoxins and thioredoxins are also enzymes involved in the detoxification of 
hydrogen peroxides within eukaryotic cell [15,49]. The former degrades hydroperoxides 
into water and can act as a redox sensor (monitoring disruption of cellular redox 
homeostasis). Thioredoxins have important roles in several vital cellular processes such 
as cell cycle regulation, cell growth, gene expression and apoptosis. 
1.3.2 Chain-Breaking Antioxidants 
Chain-breaking antioxidants are molecules found in the blood and extracellular 
fluids [30], with the ability to neutralize free radicals by breaking the chain reaction 
initiated by them (Figure 5): 
 
Figure 5 – Scheme of antioxidant activity against a free radical-initiated chain reaction. A• represents an 
inert antioxidant (with no capability to initiate a chain reaction). 
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Antioxidants can be either endogenous or exogenous [15] ( 
Table 4), and include both hydrophilic and lipophilic small-molecules [30]. Vitamin C 
is a water-soluble antioxidant capable of scavenging O2•−, OH• and ROO• radicals, as well 
as H2O2, hypochlorous acid and singlet oxygen [46] (Figure 5). Uric acid is a lipophilic chain-
breaking antioxidant that can coordinate oxidative Fe3+ ions, thus preventing the 
deleterious Fenton reaction. 
Glutathione (GSH) is an essential endogenous antioxidant responsible for keeping 
the intracellular redox homeostasis of the cell [9,15]. In the reduced state (GSH, the most 
abundant form in the reducing intracellular medium), glutathione displays a high 
antioxidant ability by scavenging a variety of free radicals and oxidative ions [15]. GSH is 
capable of capturing hydroxyl radicals and singlet oxygen directly and can be used as a 
reductant of GPxs to detoxify hydrogen peroxide and lipid peroxides [8,48]. In the oxidized 
form (glutathione disulphide, GSSG], it is mostly present in the nucleus for maintaining 
the redox state of protein sulfhydryls that are essential for DNA expression and repair [8]. 
Lipoic acid is another relevant endogenous antioxidant, sometimes referred to as 
“universal antioxidant” since it is able to quench free radicals in both hydrophobic and 
hydrophilic domains, and also to chelate pro-oxidant cations [8]. Vitamin E, a dietary 
compound, is a potent, lipid-soluble antioxidant present in low-density lipoproteins 
[15,46]. Moreover, it is very effective at breaking the chain reaction leading to lipid 
peroxidation, through peroxyl radical scavenging. Carotenoids are another relevant group 
of natural antioxidants, able to neutralize peroxy radicals and singlet oxygen [15]. 
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1.4. Dietary Polyphenols 
Polyphenols are an abundant source of micronutrients [51] with recognised 
antioxidant activity [52]. Several studies have established a direct relationship between 
the intake of this type of compounds and prevention of some oxidative stress-induced 
diseases, such as neurodegenerative and cardiovascular disorders and some types of 
cancer [53-55]. These compounds are secondary metabolites of plants (phytochemicals) 
[51,53,55,56], and are therefore widespread in fruits, vegetables, cereals, vegetable oils, 
chocolate and beverages such as tea, coffee and wine [52,55,57,58]. Phytochemicals, 
even though not considered as essential nutrients, are known to display numerous 
biological functions, from cell growth to defence against pathogens or UV radiation in 
plants [51,53,56,59]. Furthermore, they constitute the active substances found in many 
medicinal plants, being responsible for modulating the activity of a wide range of enzymes 
and cell receptors [51]. 
Polyphenols can be classified into different groups, according to their chemical 
characteristics. Over 8000 distinct structures are known [33,55,57], mostly differing in the 
number of aromatic rings and their substituent groups (Figure 3) [33,52,53,55]: phenolic 
acids, flavonoids, stilbenes, coumarins and tannins. 
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Figure 6 – Classification of dietary polyphenols. (Adapted from [51-53,60]) 
The most abundant polyphenols in the human diet are flavonoids [33,53], which 
account for about 2/3 of the total phenolic content, the remaining 1/3 being phenolic 
acids [53,56]. These can be grouped into two major subclasses: benzoic acid derivatives 
and cinnamic acid analogues (hydroxycinnamic acids, Figure 7) [33,51,52,55-57]. 
Di
et
ar
y 
po
ly
ph
en
ol
s
Phenolic acids
Hydroxycinnamic 
acids
p-Coumaric acid
Caffeic acid
Ferulic acid
Sinapic acid
Hydroxybenzoic 
acids
Flavonoids
Flavonols
Flavones
Flavanols
Flavonones
Anthocyanidins
Isoflavones
Daidzein
Glycitein
Genistein
Formonometin
Stilbens
Coumarins
Tannins
1. Biological Systems 
33 
 
 
Figure 7 – Chemical structure dietary phytochemicals. (Adapted from [57]) 
The average intake of phenol acids in a normal diet was reported to be ca. 200 
mg/day, but this value is strongly determined by dietary habits [56]. Phenolic acids and 
their derivatives have been described to possess both antioxidant and prooxidant abilities 
(depending on their concentration], as well as preventive properties towards 
cardiovascular diseases, neurodegenerative disorders, inflammatory processes and 
cancer [61-63]. 
Flavonoids comprise two C6 aromatic rings (A and B) and may be divided into 6 
groups: flavonols, flavones, flavanols, flavonones, anthocyanidins and isoflavones (Figure 
6) [51,53,55,57]. In the basic flavonoid structure the hydroxyl groups are usually at the 
4’,5’ and 7’ positions, and sugar substituents are common  (yielding flavonoid conjugates 
abundant in green plants [57]. Extensive experimental evidence (mostly from 
epidemiologic studies) suggests that flavonoids display health-promoting properties 
related to their antioxidant capacity (through both chain-breaking and radical scavenging 
processes [24]. 
This type of compounds have been the subject of intense research in the last two 
decades, and numerous studies have suggested that a diet rich in fruits, vegetables and 
cereals can significantly reduce the risk of developing pathologies attributed to 
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deleterious oxidative processes, including cancer [31,53,55,62,64]. Hence, dietary habits 
have been highlighted as an effective chemopreventive strategy against this type of 
pathologies. 
1.4.1 Hydroxycinnamic Acids  
Hydroxycinnamic acids (HCAs) are hydroxyl derivatives of cinnamic acid (Figure 7). 
They are biosynthetised from phenylalanine and tyrosine, and contain an unsaturated 
side chain with either cis or trans conformation [60]. These compounds are commonly 
present in nature as conjugates, linked (through ester bonds) to polyamines, proteins or 
cell-wall structural components (e.g. cellulose or lignin) [53]. 
HCAs are more common that hydroxybenzoic acids and comprise p-coumaric (p-Ca), 
caffeic, ferulic and sinapic acids [51-53,57,60]. Numerous studies have shown that 
cinnamic and hydroxycinnamic acids display relevant biological properties, namely 
antiproliferative effect towards several types of cancers (e.g. colon, cervical, breast and 
lung carcinomas [56,62,65]) and a potential inhibitory effect in cancer metastasis [54]. 
 
1.4.1.1 para-Coumaric acid 
trans-4-Hydroxycinnamic acid (para-coumaric acid, p-Ca) is the major HCA in citrus, 
pinnaple [34], spinach, grapes, apples, berries and tomatoes [66], being also present in 
beverages such as tea, coffee and wine [67-69]. It is one of the three geometric isomers 
of hydroxycoumaric acid (besides the orto- and meta-coumaric derivatives) [69]. In 
nature, p-CA is the most abundant of the three isomers, and is biosynthesised from 
cinnamic acid in the presence of the p-450-dependent enzyme 4-cinnamic acid 
hydroxylase [69]. Its bioavailability in humans is around 1.0 μmol/L [54]. Although the 
mechanism of action is not still fully understood at the molecular level, several studies 
have hypothesised that p-Ca´s  antioxidant properties (and potential chemoprotective 
effect) are due to quenching of carcinogenic ROS and RNS within the cell [68,70]. 
Coumaric acid has been shown to inhibit cell cycle progression and to reduce cell 
viability and colony formation in colon cancer cells [54,66,71], as well as in SW 620, Hep 
G2, A549 and T-47D cells (IC50 equal to 87, 215, 412 and 474 μM, respectively [72]). A 
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study in cadmium chloride-induced renal toxicity in rats showed that p-Ca (100 mg per kg 
per b. wt) displays an effective protective effect [73]. 
 
1.4.2 Isoflavones 
Isoflavones are a subgroup of flavonoids comprising a phenyl group at the C3 
position and a specific orientation between rings B and C (Figure 7) [55,57,59]. They are 
found in leguminous vegetables, mainly soybean and soybean derivates [41,55,65], and 
are often referred to as phytoestrogens since they can mimic estrogen activity 
[37,41,51,65,74],  the relative position of their hydroxyl groups at positions 7 and 4’ being 
analogous to that of the estradiol molecule. These compounds have shown to prevent 
cardiovascular diseases and osteoporosis [65], and decrease cancer progression [41,65]. 
 
1.4.2.1 Daidzein 
Daidzein (DA] is an isoflavone found in nuts, citrines and soybean products (e.g. 
beans, tofu, tempeh, soy milk, textured vegetable protein, flour and miso) [34,37,74]. DA 
displays structural and functional similarities to the endogenous hormone estrogen [74], 
and since some breast cancers are estrogen-dependent, this isoflavone may compete with 
natural estrogen reducing its availability and therefore inhibiting cancer cell growth [57]. 
Similarly to other isoflavones, DA has a high antioxidant activity [74], being able to induce 
neoplastic cell death in a variety of cancer types [37].  Dietary consumption of daidzein 
from soybean products has been verified to reduce prostate and breast cancers [57].  
The health-beneficial properties of phytochemicals have led to an intense search for 
novel and more efficient antioxidants from natural sources, involving the Medicinal 
Chemistry and Nutritional Pharmacology fields. Establishment of new nutritional habits is 
sough, aiming at the prevention of cancer and cardiovascular disorders through a regular 
consumption of these dietary antioxidants [24]. 
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1.5. Chemoprevention 
In 1976, Michael Sporn reported a new approach against cancer, chemoprevention 
[36,75]. He defined this approach as the use of natural, synthetic or biological agents to 
revert, suppress or prevent the development of a variety of steps within the process of 
carcinogenesis (initiation, promotion and/or progression) [75-78].  
Conventional cancer chemotherapy is associated to significant non-specific 
deleterious side effects [36,75], and in long-time treatments patients can develop drug 
resistance [36,59]. Additionally, cancer treatment is very expensive for the healthcare 
provider and to the community in general, which renders chemoprevention based on 
phytochemicals, usually inexpensive, readily applicable, acceptable and accessible [79], 
an attractive  alternative aimed at avoiding or minimising cancer incidence. Actually, 
recent studies have shown that some cancers (such as breast and colorectal) could be 
prevented in 2/3 of the cases.  
Epidemiologic studies establish that women from Asian countries display a much 
lower incidence of breast cancer than western women, this having been associated to 
dietary habits (e.g. higher consumption of soy products [75,80]. A similar scenario has 
recently been reported for prostate cancer [80]. Additionally, studies performed in 
different cell lines (breast [31] and colorectal cancer [81]), and animal models [77,80,82] 
as well as clinical trials [77,82], suggest a protective role of antioxidant dietary 
polyphenols against different types of neoplasias [77]. In fact, polyphenols have already 
been recognised as effective protective agents against cardiovascular diseases, decreasing 
mortality due to coronary heart distress and reducing the incidence of myocardial infarct 
[26,61]. 
Nowadays it is well-established that diets rich in antioxidant compounds from 
grains, fruits and vegetables are health-beneficial [25,75], and protect against the 
deleterious action of free radicals that may lead to cancer development [75] and other 
oxidative stress-induced disorders (e.g. neurodegenerative diseases). 
In addition, natural products are chemopreventive agents of choice due to their 
minimal toxicity coupled to their favourable protective capacity [31,75,80] and nutritious 
properties [75]. 
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Despite the efforts to establish the numerous advantages of chemopreventive 
strategies, controversy still remains among researchers regarding a widespread use of this 
type of antioxidants, mainly due to their concentration-dependent dual effect 
(antioxidant versus pro-oxidant) and the difficulty to accurately quantify their 
bioavailability in food products [77]. Over the years research in the nutritional, 
pharmacological and medicinal chemistry fields has aimed to find new antioxidants from 
natural sources, with particular emphasis on the prevention of cancer and cardiovascular 
disorders through dietary intervention, in view of the high morbidity of these disorders 
and the limited success of conventional chemotherapy [59]. 
Chemoprevention agents can be classified into three main groups: a) primary 
prevention, in high-risk healthy individuals; b) cancer prevention, in individuals which had 
developed pre-malignant lesions; c) continuous prevention, in cancer patients already 
treated (conventionally) for a primary tumour [83]. 
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1.6. Structure-Activity Related Mechanisms of Action 
The protective effects of compounds present in fruits and vegetables appear to be 
involved in the early rather than the later stage of carcinogenesis [75]. Experimental 
evidence suggests that antioxidants and anti-inflammatory compounds can be used to 
modify the redox environment of cancer cells, and consequently their behaviour and 
growing profile [75]. The anticarcinogenic activity of these dietary compounds is reflected 
in their cytoprotective effect towards healthy cells coupled to their cytotoxic effect 
against pre-neoplastic or neoplastic cells [77]. 
Despite the extensive knowledge on dietary polyphenols regarding their structure 
and antioxidant capacity, the mechanism of action underlying their chemopreventive 
activity has not yet been fully elucidated [84], having been generally assigned to: ROS/RNS 
scavenging [59,85,86], inhibition of oncogene activity and activation of tumour 
suppressor genes, modulation of hormone/growth factor activity, induction of terminal 
differentiation, activation of apoptosis, re-establishment of the immune response, and/or 
inhibition of angiogenesis. 
Dietary chemopreventive agents can be classified according to their different 
mechanisms of action: (i) Blocking agents, that act immediately before or during 
carcinogenesis initiation, thus preventing the interaction between carcinogenic 
compounds (e.g. exogenous or endogenous ROS/RNS) and cellular targets, through 
different mechanisms including carcinogenic detoxification, modification of carcinogen 
uptake and metabolism, scavenging of ROS and other oxidative species, and enhanced 
DNA repair [83-85,87]. (ii) Suppressing agents, which exert their effect during initiation, 
promotion and progression of pre-neoplastic cells, via radical scavenging activity, or 
inhibition of xenobiotic metabolizing enzymes [83-85,87] . Phytochemicals were also 
shown to display anti-invasive and antimitotic properties thus interfering with cell 
migration and adhesion, but the exact molecular mechanism responsible for these 
properties remains unclear [77]. 
According to several reported studies, the beneficial effects of phenolic compounds 
rely on their structure and conformation through defined Structure-Activity Relationships 
(SARs), namely the number and location of the phenolic hydroxyl groups [59,64,80], the 
nature of the spacer chain between the ring and the carboxylic, ester or amide moieties, 
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and the length of the ester group in polyhydroxylated esters [62] (Figure 8). Furthermore, 
the biological activity of these compounds is determined by their rate of incorporation 
into the cells, which is directly related to their hydrophilic vs lipophilic properties [62,64]. 
 
 
Figure 8 – Main structure–activity relationships (shadowed areas) established for isoflavones, in the 
presence (A) or absence (B) of a catechol group (from [59]). 
 
1.6.1. Hydroxycinnamic acids 
The antioxidant properties of hydroxycinnamic acids are intimately related to their 
characteristic chemical structure [54] (Figure 9). 
 
Figure 9 – Chemical structure of phenolic acids, hydroxycinnamic acid and p-coumaric acid. (Adapted from 
[57]) 
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HCAs have been associated with growth-inhibition properties towards some human 
cancer cell lines [54,64], along with a reduced risk of cardiovascular disease and other 
oxidative stress-related disorders. HCAs have a strong radical-scavenging ability (OH-
donation) related to the presence of –CH=CH-COOH groups [88] and are able to capture 
pro-oxidant metals, although other mechanisms are also suggested, namely triggering of 
gene induction/repression modulation of enzymatic activity, inhibition of cell proliferation 
and O2 scavenging [54,89]. 
1.6.2. Isoflavones 
The beneficial health effects of flavonoids (Figure 10) are described as being mainly 
due to their metal chelating ability, as well as to activation of antioxidant enzymes, 
reduction of free radicals and inhibition of oxidases [26], and is determined by the 
dissociation enthalpy of the O–H bonds present in the molecule [59]. 
 
Figure 10 – Flavonoid skeleton, isoflavone general structure and daidzein (Adapted from [57]). 
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These mechanisms are strongly structure-dependent, namely on the presence of 
2 or 3 hydroxy substituent groups in the B-ring, or of a 4-oxo function in the C-ring, 
especially when coupled to a 2,3-double bond in C-ring [59,80]. Also important are the 
additional presence of OH  substituents in ring B at either 3ʹ or 5ʹ positions and at ring A 
in postion 7 [90]. 
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1.7. The aims 
The purpose of this research work is to assess the relationship between the 
biological activity – potentially chemopreventive – of two dietary phytochemicals (p-
coumaric acid and daidzein) and their biochemical impact on human breast cancer cells, 
assessed by microRaman spectroscopy. A multidisciplinary approach was chosen, 
comprising: 
(i) Evaluation of the biological activity of the dietary compounds regarding cell 
viability and proliferation, in human breast cancer cells (estrogen-dependent/MCF-7 and 
independent/MDA-MB-231), using the MTT and SRB colorimetric tests, respectively. 
Simultaneous screening in non-tumour human breast cells (MCF-12A). 
(ii) Measurement of the ROS present in the intracellular medium, in the 
presence and absence of the phytochemicals, through a fluorimetric method. 
(iii) Assessment of the effect of the polyphenols on the cell´s metastatic, in a 
transwell invasion chamber. 
(iv) Probing of the compounds´ metabolic impact on the human breast cancer 
cells via Raman microspectroscopy of fixed cells.
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2.1 Growth-Inhibition and Cytotoxicity Assays 
In order to evaluate cell proliferation (growth-inhibition ability), the sulforhodamine 
B (SRB) colorimetric assay was used, while the reduction of 3-(4,5-dimethylthiazol-2-2yl)-
2,5-diphenyl tetrazolium bromide (MTT) was applied for determination of cellular viability 
(cytotoxic effect). p-coumaric acid and daidzein were tested at different concentrations 
and incubation times, for the human breast cancer cell lines MDA-MB-231 (estrogen-
independent) and MCF-7 (estrogen-dependent), as well as for the non-cancerous human 
breast cells MCF-12A. 
The experimental protocol followed to assess the compound´s cytotoxic and anti-
proliferative activities is schematically represented in Figure 11. 
 
Figure 11 – Main experimental steps for the SRB and MTT assays. 
For both methods, a 1 mL of a cellular suspension containing 5.79x104 cells/mL, with 
a 3.0x104cell/cm2 density were transferred to 24-wells plates (area=1.93 cm2). After 24 
hours for MDA-MB-231 and MCF-7, and 48 hours for MCF-12A, the tested compounds 
were added (from stock solutions) in suitable volumes according to the desired final 
concentration: 5 to 10 μM for p-Ca and 25 to 100 μM for DA. The cell cultures were 
incubated at 37°C. After 24 hours of incubation, the cells were harvested and analysed 
(both in the controls and in the drug-treated cultures) every 24 hours, for a total of two 
days. The cell density and viability were determined by the SRB and MTT tests, 
respectively. 
All assays were performed in triplicate (except for MCF12A which was carried out in 
duplicate), in three independent experiments. The results were compared with the 
control (untreated cells), considered for each independent experiment. 
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2.1.1. MTT Assay 
The MTT test is based on the reduction of the tetrazolium salt by viable cells. 
 
Figure 12 – Representation of MTT reduction to formazan crystals by mitochondrial dehydrogenases. 
MTT is taken up via endocytosis by living cells and is reduced to blue formazan 
crystals (Figure 12) inside the cells by mitochondrial dehydrogenases [91]. This test allows 
to measure the enzymatic activity of viable cells [92], since only the metabolically active 
ones (e.g. viable) are able to reduce MTT. The amount of formazan formed is directly 
proportional to the cell´s viability [91] and can be measured spectrophotometrically (at a 
defined wavelength). 
This method, however, presents some disadvantages: possible reduction of MTT by 
contaminants; the results depend on the cell´s metabolic state (e.g. mitochondrial 
dehydrogenases of apoptotic cells display an unchanged activity), which can lead to a 
underestimation of the effect of a compound. In view of these limitations, a second 
cytotoxicity assay is envisaged in a near future to complement the data already obtained. 
2.1.2. Sulforhodamine B assay  
The Sulforhodamine B (SRB) assay is a well-established colorimetric method for 
drug-toxicity screening in different types of cell lines (cancerous and non-cancerous, [93]). 
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Figure 13 Chemical structure of Sulforhodamina B 
Sulforhodamine B is a bright-pink aminoxanthene dye, comprising two sulfonic 
groups that can bind to basic amino acid residues of cellular proteins, under acidic 
conditions [93-95]. SRB dissociates in basic medium [93]. This colorimetric evaluation 
provides an estimate of the total protein mass, which is directly proportional to the cell 
density [93]. 
2.1.3. Transwell Migration Assay (Boyden Chamber Assay] 
Cells, particularly cancer cells, have the ability to migrate and invade tissues that can 
be quite distant from the original tumour. The transwell migration assay allows to assess 
this migration for several cell types (eg. cancer cells, leukocytes). This method is based on 
two medium-containing cavities separated by a microporous membrane through which 
cell migration is monitored [96,97] (Figure 14). 
 
Figure 14 – Represention of the Transwell migration assay. (Adapted from [96]) 
Cells with the tested compound (and without FBS) were placed in the upper 
compartment of the chamber, and were allowed to migrate vertically through the 
membrane to the lower compartment, which was filled with FBS-supplemented culture 
medium (attachment medium) [96,97]. 
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2.1.4. Evaluation of ROS/RNS by Fuorimetry 
2’,7’-Dichlorodihydrofluorescin diacetate (DCFH-DA) is a non selective cell-
permeable fluorogenic probe, which allows ROS and RNS detection [98]: DCFH-DA diffuses 
into the intracellular medium and is deacetylated by cellular esterases to non-fluorescent 
2’,7’-dichlorodihydrofluorescin (DCFH) which is quickly oxidized by the ROS/RNS present 
within the cell to the highly fluorescent 2’,7’-dichlorodihydrofluorescein (DCF species) 
(Figure 15). The intensity of fluorescence measured is therefore proportional to the ROS 
level in the cytosol [98,99]. 
 
Figure 15 – Scheme of the ROS measurement assay based on the fluorogenic DCFH-DA probe. (From 
[99]) 
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2.2. Raman Spectroscopy  
In 1928, the Indian physicist, C.V. Raman, observed, in a home-made spectrometer, 
the phenomenon of inelastic scattering of light that became known as the Raman effect 
[100,101]. On account of this discovery, he was awarded the Nobel Prize in Physics in 1930 
[100,102]. 
The Raman effect is therefore based on the interaction between an electromagnetic 
radiation and the molecules from the analysed sample [103], through to an inelastic 
process (involving energy transfer) [104,105], the shifts in energy of the scattered 
radiation from the incident frequency being a direct measure of the vibrational modes of 
the molecule [102,106]. This is a very weak effect, the Raman signals having a quite low 
intensity (ca. 5 to 9 orders of magnitude lower than the elastic Rayleigh band). Raman 
used the filtered sunlight as the incident radiation, and he needed several hours of 
irradiation to record a spectrum even for large volumes of sample [107].  
In the 1960´s the Raman technique experienced a significant progress, due to the 
development of Lasers (Light Amplification by the Stimulated Emission of Radiation), by 
C.H. Townes and A.L. Schawlow, in 1958 [108]. In 1960, T.H. Maiman observed for the first 
time the lasing action [102] and verified that these monochromatic laser sources provide 
significant brightness and intensity to partially overcome the low efficiency of the Raman 
scattering process [102]. The Raman effect couples an induced polarization of the 
scattering molecules with the molecular vibrational modes, no ‘‘absorption’’ process 
being involved [102]. In a Raman spectra, that detects scattered light, the intensity of the 
signals depends on the change in molecular polarizability during the corresponding 
vibrational transitions [106]. 
When a molecule is irradiated with photons of frequency 0 and energy h0 an 
elastic process occurs, the diffused photons having the same energy as the incident ones 
[102] (e.g. no changes occurring in the incident photon frequency) - Rayleigh scattering. 
However, another (much weaker) process also takes place, the diffused photon having a 
different frequency from the incident one (either gain or loss - 0 ± 	 due to the 
molecular vibrations within the sample [102,104,105] – Raman scattering. Two regions 
are then defined: the Stokes spectra interval, for 0 = 0 - 
 and the anti-Stokes region 
for0 = 0 +  (Figure 16). 
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Figure 16 – Electronic-vibronic energy level diagrama, showing the Stokes and anti-Stokes Raman 
scattering and the Rayleigh elastic band. (Adapted from [106]) 
Hence, Raman spectroscopy measures the fundamental vibrations of a sample, 
which depend on the number of atoms (N) in the molecule (3N-5 for linear molecule and 
3N-6 for a non-linear one), on its geometry/conformation and on the environmental 
conditions. The main vibrational modes are symmetric or asymmetric stretchings, 
deformations and torsions (Figure 17). 
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Figure 17 – Main vibrational modes of symmetric or asymmetric stretching, bending or deformation 
modes. (Adapted from [109]) 
The main components of a Raman spectrometer remain the same as those built by 
Sir Raman, but the performance of modern apparatus has greatly improved thanks to the 
development of high-quality lasers, modern charge-coupled device (CCD) detectors 
[101,102] and state-of-the-art computers with very high storage capacity. Nowadays, it is 
possible to obtain a good quality Raman spectrum from an extremely small amount of 
sample (g or l) in just a few seconds [101,107]. 
The interest in this technique has increased over the years, due to its numerous 
advantages and varied fields of application: it is non-invasive, non-destructive, can 
provide detailed spatial information and yield chemical images without the need of dyes 
or probes and with minimal sample preparation. Moreover, it is very suitable for the study 
of biological specimens, since water hardly interferes in the spectra [103,106,110]. Other 
significant advantage is the accurate information about cellular components [103,111], 
since this technique is extremely sensitive to the chemical composition of the sample (the 
Raman spectra represents an biochemical fingerprint of a molecule) [102,103,112,113]. 
Therefore, it allows to distinguish the smallest changes in a sample and can thus be used 
to monitor the composition, physical state and structure/conformation of a compound 
[102,105]. 
For biological samples, in particular, it is possible to achieve sub-cellular resolution 
and identify organelles and biomolecules, as well to obtain information about the 
chemical composition of cells under different conditions (e.g. pH, temperature, ionic 
strength, presence of drugs or xenobiotics) [100,101,105]. 
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Nevertheless, the Raman effect is extremely week and can be masked by the 
sample´s autofluorescence [101,113]. In order to overcome these drawbacks, some 
techniques were developed, namely: (i) resonance Raman, involving the irradiation of the 
sample with a wavelength equal (or near) to the compound´s absorption maximum in the 
Visible region [100], allowing a magnification of the vibrational modes close to the 
chromophore moiety of the molecule; (ii) SERS (Surface-enhanced Raman Spectroscopy), 
by adding a metal colloid (e.g. of Au, Ag, Cu) to the sample, that will adsorb to it leading 
to an enhancement of the Raman bands from the oscillators that are closest to the metal 
surface [114]. 
Additionally, care should be taken regarding the use of high laser intensities (which 
would also increase the Raman bands to a certain degree), since this may cause local 
heating in the sample and possible damage. Also, it is possibly to minimize fluorescence 
by varying the wavelength of the exciting radiation (that should be different from the 
Visible absorption maximum of the sample) [101,115,116]. The choice of the most 
suitable excitation source is therefore very important, mainly when analysing biological 
specimens. At present, there is a wide range of lasers available with varied wavelengths 
(from the near-IR to the UV) namely 514, 532, 632, 647, 785 and 1064 nm [100,101]. Less 
energetic red laser sources such as He-Ne (633 nm) or diode lasers (785 nm) are also very 
helpful and widely applied in the study of biological samples [102,103,106,115]. 
In the last decade Raman spectroscopy has become a powerful and well-established 
analytical technique [100,103,104] , more and more applied for the study of cells and 
tissues [117-124]. Additionally, the technique has been shown to be of invaluable 
effectiveness in drug development [125,126], medical diagnosis (e.g. optical biopsies as 
opposed to conventional tissue removal for histological analysis) [100,127-131] and even 
for use in the operating theatre during surgical resection of tumours with a view to 
accurately distinguish cancerous from healthy tissue. Raman spectroscopy is also applied 
in areas such as microbiology [132-136], nanomedicine [61,112,137], forensic science 
[100,138,139], and archeometry and cultural heritage [140-144]. 
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2.2.1. Raman microspectroscopy 
The birth of Raman microspectroscopy dates from the early 1970´s, when Delhaye 
and Dhamelincourt, in the University of Lille (France), combined optical microscopy with 
Raman light scattering [115,116,145]. The further implementation (fifteen years later) of 
confocal Raman configurations by Puppels and coworkers [146-148] allowed to obtain 
data at a very high spatial resolution (cellular and sub-cellular), with a high signal-to-noise 
ratio and low underlying spectral backgrounds [145]. A Raman microspectrometer is 
configured with an optical microscope, a NIR laser and a CCD detector that promote the 
signal improvement, this combination reducing the acquisition time and the fluorescence 
interference [113] (Figure 18). 
 
 
Figure 18 – Representation of a Raman microspectrometer. (Adapted from [103]) 
Raman microspectroscopy allows to analyse extremely small amounts of sample, 
even for inhomogeneous biospecimens, and yields detailed information on tissues and 
cell structure and composition with excellent quality and resolution [101]. Single cell 
analysis is also possible, yielding relevant data for understanding cellular process as well 
as the impact of exogenous compounds (such as chemoprevetive agents or drugs) on the 
cell´s biochemical profile. Actually, microRaman analysis is a label-free technique that 
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allows the direct observation of macromolecules inside a living cell without disturbing the 
system, and gives spatially resolved biochemical information [102,115,117,149-151]. For 
cells, the so-called spectral signature can be obtained, comprising bands corresponding to 
the different cellular components: nucleic acids, proteins, lipids, carbohydrates and other 
metabolites (Table 5). Furthermore, Raman microspectroscopy can be applied to either 
live or fixed cells, preserving cell integrity and function (provided the laser frequency and 
power are carefully chosen). 
Table 5 – Principal vibrational modes assignments. 
Assignment wavenumber (cm-1) Vibrational modes 
DNA and RNA   
Adenine 729 
1220-1284 
1342 
1420-1480 
1578 
 
Cytosine 782 
1245-1275 
ν(C=C)sym breathing 
 
Guanine 667 
1320 
1342 
1420-1480 
1578 
 
Thymine 667 
746 
1220-1284 
 
Uracil 1135 
1235 
1395 
 
Phosphates 788 
811 
828 
1060-1095 
ν(O-P-O)sym  
ν(O-P-O)RNA 
ν(O-P-O)asym (B-DNA) 
ν(PO2-) 
Carbon skeleton  914-925 
1420-1480 
ν(C-C) ν(C-O)Ribose-Phosphate 
δ(CH2), δ(CH) 
Proteins   
Phenylalanine 621 
1005 
1033 
1209 
1607 
twist (C-C) 
ν(C=C)sym breathing 
δ(C-H)ip 
ν(C-C6H5) 
ν(C=C) 
Tyrosine 645 
828, 854 
1176 
ν(C-C) 
ν(C=C)sym breathing  
δ(C-H) 
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1617 ν(C=C) 
Tryptophan 875-880 
1553 
H bonds/indol ring 
ν(C=C) 
Amide I  
1650-1660 
1670-1680 
ν(C=O) 
α-helix 
β-sheet 
Amide III  
1250 
1264 
1267 
ν(C=O) + δ(CNH) 
β-sheet  
Random 
α-helix 
 937 
980 
1106-1120 
1158 
1384 
1420-1480 
ν(C-C) α-helix 
ν(C-C) β-sheet 
ν(C-N) 
ν(C-C), ν(C-N) 
δ(CH3) 
δ(CH2/CH) 
Lipids   
 717 
891, 908 
1080 
1060-1095 
1259 
1301 
1384 
1420-1480 
1650-1660 
1736 
ν(CN+(CH3)3) 
δ(CH2) 
ν(PO2-)sym 
ν(C-C) 
ν(PO2-)asym 
twist CH2 
δ(CH3) 
δ(CH2), δ(CH) 
ν(C=C) 
ν(C=O) 
Polysaccharides   
 877 
1025,1047,1155 
1060-1095 
1384  
1420-1480 
C-O-H ring 
ν(C-O)glycogen 
ν(C-O), ν(C-C) 
δ(CH3) 
δ(CH2/CH) 
Glycose 937 C-O-H 
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3.1. Reagents, Materials and Equipment 
3.1.1. Materials and Equipment 
The compounds and reagents used along this project are described in Table 6. 
Table 6 – List of compounds and reagents used along the present work. 
Product Laboratory 
Fetal bovin serum (FBS) Invitrogen (Barcelona, Espanha) 
Penicillin-Streptomycin Antibody (10 
units/ml Pen and 10 μg/ml Strep) 
Tris (hydroxymethyl) aminomethane or 
Tris 
Pational Diagnostic (Hessle Hull, United 
Kingdom) 
Acetic acid, glacial 
Sigma-Aldrich 
(Sintra, Portugal) 
3-(4,5-dimethylthiazol-2-y)-2,5-
diphenyltetrazolium (MTT ≥97.5%) 
2ʹ,7ʹ-Dichlorofluorescin diacetate (DCFH-
DA ≥97%) 
Dimethyl sulfoxide (DMSO ≥99.9 %) 
p-coumaric acid (p-CA ≥98,0%) 
Sodium bicarbonate (NaHCO3) 
Sodium phosphate buffer pH 7.4 (PBS) 
Sulforhodamine B (SRB) 
Trypan Blue Solution (0.4%) 
Trypsin 
Multiwell plates (24, 48 and 96 plates) 
and culture flasks T 75 cm2 
Orange Scientific (Braine- l'Alleud, Bélgica) 
Daidzein (97%) Alfa Aesar (Lancashire, United Kingdom) 
 
The equipment used in this project is described in Table 7. 
Table 7 – List of equipment used with mark and model 
Equipment Mark Model 
Analytical balance Mettler  Toledo AB54 
Centrifuge with cooling MPW  MPW-350R 
Culture chamber with 
vertical laminar flow (flow 
rate : 1050m3/h) 
BioWizard  BioWizard - 100 
Incubator Sheldon Mfg. Inc  3517-2 Waterjacket CO2 
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PH meter Sargent-Welch  IP 
Shaker " Vortex " IKA  MS2 Minishaker 
Visible/UV 
spectrophotometer (with 
Gen5 software) 
BioTek  μQuant MQX200 
Water purification 
apparatus Milli -Q 
TKA  GenPure 
 
3.1.2. Solutions 
The compounds under study were solubilized in DMSO (due to low water solubility), 
in the concentration range 5 to 100 μM. The final concentration of DMSO in the culture 
medium did not exceed 0.1% (v/v). A 0.01% DMSO solution was always considered as a 
control. 
All solutions were prepared and filtered before use, and were stored in the dark to 
avoid photodegradation of the phenolic compounds. Trypan blue was used in 0.04% (v/v) 
solution in PBS. MTT (3-(4,5-dimethylthiazol-2-2yl)-2,5-diphenyl tetrazolium bromide) 
was prepared in PBS solution, in a concentration of 0.5mg/ml. 
Initially, high concentrations of para-coumaric acid were tested (100 to 1600 M) 
but in these conditions p-Ca showed to be cytotoxic, most probably due to the pro-oxidant 
effect known for these phenolic acids at very high dosages, that can interfere with 
relevant secondary metabolic pathways. 
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3.2. Biological System 
3.2.1. Cell culture 
The human cell lines choosen for this work were MCF-7, MDA-MB-231 and MCF-
12A (Figure 19). MCF-7 has estrogen (ER+) and EGF receptors and is uninvasive, whereas 
MDA-MB-231 is a more aggressive, hormone-independent (ER-) breast cancer [152]. MCF-
12A is non-tumour immortalised cell line of breast tissue. 
 
Figure 19 – MCF-7 (breast cancer cell line estrogen dependent), MDA-MB-231 (breast cancer cell line 
hormone-independent] and MCF-12A (non-tumour immortalized cell line of breast tissue) cell 
lines. Images obtained in a microscopy with 100x magnification (MCF-7) and 1000x 
magnification (MDA-MB-231 and MCF-12A). 
The MDA-MB-231 and MCF-7 cells were cultured in monolayer, in Dulbecco’s 
modified Eagle’s high glucose (4500mg/L) medium (DMEM-HG), supplemented with10% 
(v/v] heat-inactivated fetal bovine serum (FBS) and 1% penicillin-streptomycin. MCF-12A 
]was also cultured in monolayer, in a 1:1 mixture of Dulbecco's modified Eagle's medium 
and Ham's F12 medium, supplemented with hydrocortisone, human epidermal growth 
factor (EGF), bovine insulin and 5% heat-inactivated horse serum with 1% penicillin-
streptomycin. All cells line were incubated at 37ºC under 85% relativity humidity and 5% 
CO2. The FBS and horse serum were previously subject to thermal inactivation at 56ºC, for 
30 minutes (to inactivate the complement and reduce the cytotoxicity caused by 
immunoglobulin’s). 
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The cell subcultures were prepared in 75 cm2 flasks, according to their 
characteristics of growth. The cell lines were subcultured twice a week, using a 
dissociation medium containing 0.05% trypsin-EDTA. All experiences were performed in 
cell cultures with less than 50 passages. 
The tested compounds were added during the cells´ exponential grow phase. 
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3.3. Methods 
3.3.1. MTT assay 
The MTT solution (0.5 mg/ml) was prepared in PBS and filtered for sterilization and 
removal of insoluble residues. To determine cellular viability (for the different cell lines 
MDA-MB-231, MCF-7 and MCF-12A), the medium was removed and the cells were 
washed with 500 μl of PBS. MTT solution (250 μL) was then added, the plates were 
incubated at 37ºC for 3 hours (always light protected) and the MTT solution was 
discarded. The newly formed formazan crystals were dissolved in DMSO, yielding a purple 
colour solution, for which the absorbance was read (in each well) at 570 nm (in a multiwell 
plate reader). Cellular viability was determined according to the equation: 
 
% Cellular viability = 
Asample 
x 100 (1) 
Acontrol - Ablank 
where Asample is the absorption of solutions exposed to the compound tested (after 
subtracted of the absorption of the blank (DMSO)); Acontrol represents the absorption of 
the control samples (upon blank subtraction). 
The results are presented as a percentage relative to the control (always taken as 
100%). 
 
3.3.2. SRB assay 
In order to perform this assay, incubation with the phytochemical (either p-CA or 
DA) was ended every 24 hours during two days, the cells were washed with 500 μl of PBS 
and 500 μl of water Mili-Q, after they were fixed with 1%-acetic acid in methanol and 
frozen overnight. Upon thawing and drying, 250 μl SRB in 1%-acetic acid was added to 
each well, followed by incubation at 37ºC for 1h, after which the cells were then carefully 
washed with 1%-acetic acid and dried. 1 ml of 10mM-Tris (ph 10) was then added to 
dissolve the protein-bound SRB, and absorbance was read at 540nm (in a multiwell plate 
spectrophotometer). 
The percentage of proliferation or cellular growth was calculated by: 
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% Cell grow = 
ܣsample − ܣ0 day 
× 100 (2) 
ܣcontrol − ܣ0 day 
 
where: Asample represents the absorption of solutions exposed to the tested compound, 
after subtraction of the absorption for the blank (Tris 10mM);ܣ0 day is the absorption of 
the control at t=0 h (corresponding to the cellular density without the compound), after 
blank subtraction. 
The results are shown as a percentage relative to the control (always taken as 
100%). 
 
3.3.3. Transwell Migration Assay (Boyden Chamber Assay] 
This assay was carried out in plates of 24 wells containing the inserts, each of which 
was carefully coated with 0.1 ml-Matrigel diluted in a 0.01M-Tris (pH 8.0)/0.7%-NaCl 
solution (coating solution) (this procedure was performed on ice). The plate was then 
incubated at 37ºC for 2 hours, after which 0.5 ml of cell suspension and compounds to be 
tested are added (at a 5x104 cells/ml density) into the insert and 0.75 ml of attachment 
medium was add to the chamber. Invasion chambers are then incubated at defined time 
points. Upon these periods inserts are scrub to remove the non-migrating cells, and the 
migrated cells are fixed with 4%-formalin and stained with 0.1%-crystal violet. In order to 
quantify the invading cells, microscopic images were captured in different points and the 
cells were counted (in triplicate). The percentage of migrating cells were calculated 
according to Equation 3: 
% Migration = 
mean number of cells insert with study compound 
× 100         (3) 
mean number of cells insert control 
 
The results are represented as a percentage of the control (taken as 100%). 
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3.3.4 ROS/RNS Measurement 
In order to perform this assay, incubation with the phytochemicals (either p-CA or 
DA) was ended after 48 hours, the cells were washed twice with PBS (2x500 μl), and 150 
μl of DCFH-DA (prepared in FBS-free culture medium) were added, after which the cells 
were incubated for 30 minutes. After removing solution, the cells were washed with PBS, 
trypsinized, resuspended with PBS and centrifuged. Upon discarding the supernatant the 
cells were ressuspended in PBS (250 μl) and fluorescence was measured 533nm (emission) 
with an excitation radiation at 480 nm. The percentage of free radical oxygen and nitrogen 
species presented was calculated according to: 
% ROS/RNS = 
ܣsample  
× 100 (4) 
ܣcontrol  
where Asample is the absorption of the samples exposed to the compound tested, and 
Acontrol represents the absorption of the control samples. 
The results are presented as a percentage relative to the control (always taken as 
100%). 
 
3.3.5. Raman Microspectroscopy 
Preparation of the Cell Samples 
The cells (MDA-MB-231 and MCF-7) were transfected at a 3.0x104cell/cm2 density, 
in 12-well plates, each well containing the optical substrate (MgF2 disks). After 24 hours 
to allow cell attachment to the substrate, p-Ca and DA were added, according with the 
desired final concentrations (5 to 10 μM and 25 to 100 μM). Upon a 48 hour incubation 
(at 37°C in a 5% CO2 atmosphere), the cells were washed twice with 1ml PBS, fixed with a 
4% formalin solution for 20 minutes, and washed again (2x) with 1ml H2O. These samples 
were kept in the fridge (ca. 5 oC, to avoid fungal contamination) with PBS prior to the 
Raman analysis. Apart from the treated-cell samples, a control (without the compounds) 
was prepared. 
Spectra Acquisition 
The Raman experiments were performed at the Department of Physical-Chemistry 
of the University of Malaga (Spain). 
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The spectra were obtained at room temperature, in a Renishaw Reflex inVia Raman 
microspectrometer coupled to a RenCam CCD (Charge Coupled Device) detector. The 785 
nm line from a diode laser was used as the exciting radiation, yielding approximately 55 
mW (solid p-Ca and DA) and 0.11 mW (cells) at the sample position. A spectral window of 
0 to 2000cm-1 was used for the pure phenolic compounds, while for the cells the spectra 
were recorded between 500 and 1800 cm-1. In both cases, a 100x magnification was used 
(Leica lens, NA=0.9, fd=0.27mm), and the data was recorded with an integration time of 
10 s and 5 scans. 
Mapping experiments were also carried out, although these results are not 
presented in this work. 
 
3.3.6. Statistical Analysis 
All experiments were performed in triplicate. The results are expressed as the 
mean±SEM. Statistical treatment was performed using the One-Way ANOVA analysis of 
variance, followed by post hoc test Turkey’s and Dunnett’s multi-comparison tests for the 
SRB and MTT results, respectively. The differences were considered significant for 
*p<0,05, **p<0,01, and ***p<0,001. 
The MicroRaman spectra were analyzed with the programs OriginPro 8 and 
MathLab R 2014b. Interpretation of these results was carried out upon multivariate 
analysis (unsupervised PCA), after baseline correction, spectral mean vector 
normalisation and smoothing (Savitzky–Golay, 11 points, first polynomial), followed by 
detraining (2nd or 4th polynomial [153]). 
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4.1. Evaluation of the Metabolic Impact of the Dietary 
Polyphenols in Human Breast Cancer Cell Lines 
Breast cancer is the second most lethal cancer among women, which justifies the 
growing research in this field over the years, particularly regarding new agents, natural or 
synthetic, with chemopreventive and antitumour properties. Cytotoxicity screening of 
these compounds, in particular, gives important information for selecting the most 
promising ones for further studies, while Raman spectroscopy experiments provide 
knowledge on their impact on the cellular components by yielding the chemical profile of 
a suitable cell model in the absence and presence of the investigated agents. 
The present study focuses on the effect of a hydroxycinnamic acid (para-Coumaric 
acid) and an isoflavone (daidzein) on a human breast cancer cell line. Previous studies 
have suggested that these compounds have a significant role in reducing several types of 
cancer, namely SW620, HT 29 (colon cancer cells), Caco-2 (colonic cell line) and also T-47D 
(epithelial ductal breast cancer) [42,65,66,72,154,155]. However, for polyphenols the 
majority of the reported studies refer to plant extracts and thus do not evaluate the effect 
of p-Ca alone [156-158], its impact on cells being unknown to this date. 
4.1.1. Structural Features of p-Coumaric Acid and Daidzein 
Despite the very similar structures of p-coumaric (p-Ca) and caffeic (CA) acids, that 
share a common polyphenolic structure, their Raman spectra reflects the different ring 
substitution pattern – CA being a dihydroxylated compound as compared to the 
monohydroxylated p-Ca (Figure 20). 
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Figure 20 – Raman microspectroscopy and FTIR experimental spectra and optimised structures for caffeic 
(from [159]) and para-coumaric acids.  
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In this type of systems, any structural change can lead to a significant variation in 
activity and cell selectivity (even leading to inefficiency). The number and position of the 
OH groups in the aromatic ring, for instance, are determinant of antioxidant activity, as 
well as the double bond in the ring pendant arm [160]. Compounds with a double bond in 
the carboxylic acid moiety were shown to have an increased chemopreventive effect at 
low concentrations, as compared to their saturated analogues. Furthermore, the 
biological activity of this kind of systems is strongly concentration-dependent: the existing 
studies evidence a preventive effect for low concentrations, while suggesting a reverse 
outcome (pro-oxidant] for higher dosages. 
The health-beneficial properties of isoflavones rely in the distinct substitution 
patterns of their chromone core. Although the chromone moiety seems to have an 
essential role for biological activity, other structural parameters are determinant such as 
the nature, number and position of the different substituent groups in rings A, B and C 
[59] (Figure 21). 
 
Figure 21 – A: Basic chromone structures (the atom numbering and ring labeling is included). B: Daidzein 
compound in study (Adapted from [59]) 
Additionally, these affect water solubility which is an important parameter in the 
use of isoflavones as chemopreventive agents in vivo [90]. Furthermore, the capacity of 
these compounds to conjugate with proteins, enzymes and diverse biological receptors 
within a biological matrix (cell or tissue) is strongly dependent on their three-dimensional 
conformation and electronic distribution. In general, the areas of highest electronegativity 
within an isoflavone are at the 5-hydroxyl and 7-hydroxyl positions of the A-ring, as well 
as at 3´ and 4´ hydroxylation sites on the B- ring (Erro! A origem da referência não foi 
encontrada.) [59]. 
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Figure 22 – Raman experimental spectra and optimised strutures for daidzein and p-coumaric acid (from 
[161]). 
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4.1.2. Evaluation of the Cytotoxic and Cell Growth-Inhibition Activities of 
p-Coumaric Acid and Daidzein 
Cytotoxicity evaluation is a conventional method used in research and development 
of new compounds aimed as chemopreventive and/or antineoplastic agents. 
The cytotoxicity effects of 4-trans-hydroxicinnamic acid (p-Ca) and 4ʹ,7-
dihydroxyisoflavone (daidzein) were evaluated towards human breast cancer cells, both 
estrogen independent (MDA-MB-231) and estrogen dependent (MCF-7), using the MTT 
reduction assay (describe in 3.3.1. section) for viability measurement, and the SRB 
colorimetric test for cell density quantification. Comparison with a human breast non-
neoplastic immortal cell line (MCF12A) was also carried out. 
 
4.1.2.1. p-Coumaric Acid 
p-Ca was tested at low (5 to 15 μM) and high (25 to 100 μM) concentrations, for 
incubation times of 24, 48 and 72 h (Figure 23). The data for 72 h is not presented, as it 
showed not to be relevant since it is identical to the data gathered at 24 hours. For the 
MCF-7 cells, at both 24 and 48 hours, the higher concentrations of p-coumaric acid seem 
to induce a slightly protective effect (potentiating cell growth and viability), although this 
effect was not found to be statistically significant. For the MDA-MB-231 cell line, this 
protective effect was more marked, leading to an increase in cell viability at 48 hours of 
87% at 50 μM and 102% at 100 μM.  
Paula Sofia Coutinho Medeiros 
74 
 
 
Figure 23 – Cytotoxic effect of p-coumaric acid against breast cancer cells (MCF-7 and MDA-MB-231), at 
24 and 48 hours incubation times. The results, obtained by the MTT assay (3.3.1. section), are 
presented as a percentage of the DMSO control (cell treated with the DMSO vehicle) 
considered as 100% (horizontal dashed line). The data are the mean ±SEM of values obtained 
for 3 independent experiments initiated and treated in parallel (n= 3). Cells were plated at a 
density of 3.0x104 cell/cm2. The results were statistically analysed in GraphPad Prism 6.00, 
applying the One-way ANOVA algorithm with Dunnett’s test for multi-comparisons: *p < 0.05, 
**p < 0.01, ***p < 0.001 vs control cultures. 
The MTT assay evaluates cell viability by the mitochondria ability to reduce 
formazan (as described in section 3.3.1.), although this method does not directly measure 
mitochondrial damage. Since oxidative stress conditions can affect mitochondria, it is 
possible that at the higher concentrations tested p-Ca may lead to an increase in ROS 
levels, which can affect mitochondria desidrogenases rendering them dysfunctional or 
allowing the cell to escape from apoptosis. Posadino and collegues (2013) [162] suggested 
that p-Ca can have different effects depending on its concentration: an antioxidant effect 
at low concentrations and a cytotoxic one at higher dosages. Based on the knowledge that 
the ROS level is higher in cancer relative to healthy cells [163], the present results suggest 
that p-Ca can have a pro-oxidant effect on breast adenocarcinoma cells, increasing ROS 
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levels and promoting an enhanced cell viability. This is in accordance with reported work 
[84,162], that unveiled a relationship between the presence of an unsaturated pendant 
chain in polyphenolic acids and a cell viability increase, namely for p-Ca at high 
concentrations. 
Regarding the lower concentrations (5 to 15 μM), p-coumaric acid was found to 
exert different effects towards the MCF-7 cells, depending on the incubation period: a 
cytotoxic effect was observed at 24 hours, particularly for 15 μM with a 50% viability 
reduction, while at 48 hours no significant differences were detected relative to the 
control. For the MDA-MB-231 cell line, in turn, p-Ca displayed a protective capacity at 48 
hours only for 5 and 7.5 μM concentrations. 
In both concentration ranges, p-Ca seems to be cell line selective, since the effects 
on MCF-7 are less pronounced (or even inexistent) compared to those on the estrogen-
independent cell line MDA-MB-231. This selectivity regarding the cell model has been 
previously observed for other types of compounds [164,165]. 
The data obtained from the SRB colorimetric (Figure 24) test did not reveal 
statistically significant differences relative to the MTT results, for all concentrations tested 
and the two cell lines under study. However, a decrease in the intracellular protein density 
was measured for MCF-7 at 48 hours incubation with p-Ca, from 7.5 to 15 μM and 75 and 
100 μM (Figure 24). Furthermore, a blocking of protein synthesis appears to occur for the 
lowest concentration range 
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Figure 24 – Cytotoxic effect of p-coumaric acid against breast cancer cells (MCF-7 and MDA-MB-231), at 
24 and 48 hours incubation times. The results, obtained by the SRB assay (3.3.2. section], are 
presented as a percentage of the DMSO control (cell treated with the DMSO vehicle) 
considered as 100% (horizontal dashed line]. The data are the mean ±SEM of values obtained 
for 3 independent experiments initiated and treated in parallel (n= 3). Cells were plated at a 
density of 3.0x104 cell/cm2. The results were statistically analysed in GraphPad Prism 6.00, 
applying the One-way ANOVA algorithm with Turkey’s test for multi-comparisons: *p < 0.05, 
**p < 0.01, ***p < 0.001 vs control cultures. 
Comparing the SRB and MTT data, it can be hypothesised that p-Ca improves cell 
viability without interfering with the cellular protein density in MDA-MB-231 cells, while 
in MCF-7 the protein density stabilises for the low concentration range, suggesting that 
the phenolic acid may interfere with protein synthesis. 
 
4.1.2.2. Daidzein 
Daidzein was found to exert a cytotoxic effect in both breast cancer cell lines (MCF-
7 and MDA-MB-231) for incubation periods well below 24 hours (Figure 25): while for 
MDA-MB-231 the viability is affected only at 75 and 100 μM (ca. 50%), a DA-induced 
viability decrease was detected for the MCF-7 cells at concentrations 50, 75 and 100 μM 
(with a 42% viability reduction for the highest concentration). 
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Figure 25 – Cytotoxic effect of daidzein against breast cancer cells (MCF-7 and MDA-MB-231), at 24 and 
48 hours incubation times. The results, obtained by the MTT assay (3.3.1. section), are 
presented as a percentage of the DMSO control (cell treated with the DMSO vehicle) 
considered as 100% (horizontal dashed line). The data are the mean ±SEM of values obtained 
for 3 independent experiments initiated and treated in parallel (n= 3). Cells were plated at a 
density of 3.0x104 cell/cm2. The results were statistically analysed in GraphPad Prism 6.00, 
applying the One-way ANOVA algorithm with Dunnett’s test for multi-comparisons: *p < 0.05, 
**p < 0.01, ***p < 0.001 vs control cultures. 
These results, reflecting a more significant effect towards the estrogen-dependent 
MCF-7 cell line versus the estrogen-independent MDA-MB-231 were foreseen, since the 
isoflavone daidzein displays a structure similar to estrogen (Figure 26) (thus being 
expected to interact effectively with estrogen receptors therefore inhibiting estrogen 
synthesis and gene expression [59,65,155]. 
 
Figure 26 – Chemical struture of estrogen and daidzein. 
In MDA-MB-231 cells, which lack estrogen receptors, DA may interfere with other 
metabolic pathways, probably oxidative-related ones, and exert an antioxidant effect. 
The SRB results (Figure 27) for DA did not show any significant changes in protein 
density for either of the two tested cell lines. Nevertheless, a very slight decrease 
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measured for 50 and 100 μM dosages may suggest that the isoflavone is somewhat 
interfering with protein synthesis (as previously observed for p-Ca). 
 
Figure 27 – Cytotoxic effect of daidzein against breast cancer cells (MCF-7 and MDA-MB-231), at 24 and 
48 hours incubation times. The results, obtained by the SRB assay (3.3.2. section), are 
presented as a percentage of the DMSO control (cell treated with the DMSO vehicle) 
considered as 100% (horizontal dashed line). The data are the mean ±SEM of values obtained 
for 3 independent experiments initiated and treated in parallel (n= 3). Cells were plated at a 
density of 3.0x104 cell/cm2. The results were statistically analysed in GraphPad Prism 6.00, 
applying the One-way ANOVA algorithm with Turkey’s test for multi-comparisons: *p < 0.05, 
**p < 0.01, ***p < 0.001 vs control cultures. 
Both the MTT and SRB results clearly show that DA affects cell viability and may 
interfere with the cellular protein content. Hence, it is suggested that the biological effect 
exerted by these dietary compounds is cell- and concentration-dependent (in accordance 
with the literature). 
Assays were also carried out for the non-tumour human breast cell line (MCF-12A), 
for chosen concentrations of the phytochemical compounds (according to the previous 
data on the neoplastic cells): 7.5 and 15 μM for p-Ca, and 50 and 100 μM for DA. A 
protective effect was verified (by the MTT assay) for DA-50 μM at 24 h, as well as for p-
Ca-7.5 μM at 48 hours (Figure 28) (higher concentrations was not study for this cell line, 
although, it was considered to do in future). 
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Figure 28 – Cytotoxic effect of p-coumaric acid and daidzein against non-tumour breast cells (MCF-12A), 
at 24 and 48 hours incubation times. The results, obtained by the MTT assay (3.3.1. section), 
are presented as a percentage of the DMSO control (cell treated with the DMSO vehicle) 
considered as 100% (horizontal dashed line). The data are the mean ±SEM of values obtained 
for 2 independent experiments initiated and treated in parallel (n= 2). Cells were plated at a 
density of 3.0x104 cell/cm2. The results were statistically analysed in GraphPad Prism 6.00, 
applying the One-way ANOVA algorithm with Dunnett’s test for multi-comparisons: *p < 0.05, 
**p < 0.01, ***p < 0.001 vs control cultures 
The SRB results obtained for these non-neoplastic cells confirmed the MTT data, no 
statistically significant differences relative to the control having been found (Figure 29). 
No cytotoxic effect against healthy cells was observed for these compounds, in the 
investigated concentration range. For some of the conditions tested, a chemoprotective 
activity can be inferred. This is a relevant result, attending to the daily consumption of 
these compounds through the diet. 
 
Figure 29 – Cytotoxic effect of p-coumaric acid and daidzein against non-tumour breast cells (MCF-12A), 
at 24 and 48 hours incubation times. The results, obtained by the SRB assay (3.3.2. section), 
are presented as a percentage of the DMSO control (cell treated with the DMSO vehicle) 
considered as 100% (horizontal dashed line). The data are the mean ±SEM of values obtained 
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for 2 independent experiments initiated and treated in parallel (n= 2). Cells were plated at a 
density of 3.0x104 cell/cm2. The results were statistically analysed in GraphPad Prism 6.00, 
applying the One-way ANOVA algorithm with Turkey’s test for multi-comparisons: *p < 0.05, 
**p < 0.01, ***p < 0.001 vs control cultures. 
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4.1.3. Assessment of Cell Migration Inhibition 
Transwell migration experiments (Boyden Chamber Assay) were performed, 
allowing to evaluate the cells´ migration and invasiveness abilities (in a biological matrix, 
to tissues other than the one containing the primary tumour) as a function of 
concentration, for a 72 h incubation period with either p-Ca or DA. This assay was only 
considered for the MDA-MB-231 cell line, as MCF-7 does not have an invasive potential. 
The results thus obtained evidence that DA at 100 μM reduces cell migration by 40% at, 
while p-Ca has 20% and 30% efficiencies at 7.5 μM and 15 μM, respectively (Figure 30). 
 
Figure 30 – Inhibition of cell migration by p-coumaric acid and daidzein, in the human invasive breast 
cancer cells MDA-MB-231, at 72 hours, by Transwell Migration Assay (Boyden Chamber 
Assay) (in section 3.3.3.). The results are present in percentage related with control cultures 
(cell treated with the compound vehicle, DMSO), considered 100% (horizontal dashed line). 
Every cultures were plated with 3.0x104 cell/cm2 density. The results for each condition, the 
values present are the mean ± SEM of values obtain for five different culture (triples) initiated 
and treated in parallel (n= 5). The data were statistic treat in GraphPad Prism 6.00, applying 
One-way ANOVA with Dunnett’s test for multi-comparisons: *p < 0.05, **p < 0.01, ***p < 
0.001 vs control cultures. 
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Matrix metalloproteinases (MMPs) are zinc-dependent proteins associated to cell 
migration and metastasis formation, which are activated by an increase in the ROS level 
[31,32]. p-coumaric acid, with well recognised antioxidant properties, is proposed to act 
against cell migration through scavenging of oxidative species, thus inhibiting activation 
of MMPs. In fact, p-Ca was found to have an inhibitory effect in ROS-induced endothelial 
cell migration and angiogenesis [69]. Daidzein, in turn, was found along this work to affect 
cell viability, which can have consequences in cell migration. Moreover, DA is known to 
downregulate MMP-2 [42], which can also lead to a reduced cell migration. 
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4.1.4. ROS/RNS Measurement 
Evaluation of the ROS/RNS levels present in the intracellular medium was 
performed for both the MCF-7 and MDA-MB-231 cells, after 48 hours exposure to the 
tested compounds. 
The preliminary results currently obtained show clear differences among these cells 
lines, for both p-Ca and DA: MCF-7 displays an ROS/RNS increase for p-Ca at 7.5, 15 and 
50 μM and DA at 100 μM, while for MDA-MB-231 the amount of free radicals only 
increases significantly for p-Ca-50 μM (Figure 31). 
 
Figure 31 – ROS/RNS measurement in the MCF-7 and MDA-MB-231 cell lines (3.0x104 cell/cm2), after 
incubation with p-coumaric acid and daidzein, using the fluorigenic probe DCFH-DA (see 
section 3.3.4.). The results are represented as a percentage relative to the control (untreated 
cells) considered as 100% (horizontal dashed line), and are the mean±SEM of the values 
obtained for three independent measurements, carried out in triplicate (n= 3). The data were 
statistically treated in GraphPad Prism 6.00, applying One-way ANOVA with Dunnett’s test 
for multi-comparisons: *p < 0.05, **p < 0.01, ***p < 0.001 vs control cultures. 
Overall, the MCF-7 samples containing p-Ca displayed much higher ROS/RNS levels 
than the estrogen-independent cells MDA-MB-231 incubated with the same phenol. Thus, 
p-coumaric seems to behave as a very cell-selective compound, with a pro-oxidant effect 
in the concentration range 7.5-50 M for MCF-7, and only for high dosages (ca. 100 M) 
for MDA-MB-231. 
Daidzein evidences a similar cell-selective effect, ROS/RNS levels clearly increasing 
with isoflavone concentration for the estrogen-dependent line (MCF-7), while for MDA-
MB-231 they are virtually unchanged by exposure to this compound [98] 
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4.1.5. Metabolic Impact of p-Coumaric Acid and Daidzein Evaluated by 
Raman Microspectroscopy 
Raman microspectroscopy experiments were carried out, in order to assess the 
metabolic impact of the dietary polyphenols p-coumaric acid and daidzein in human 
breast cancer cell lines (MDA-MB-231 and MCF-7). Particular conditions were chosen, in 
the light of the previous assays (mainly MTT results), regarding concentration and 
incubation times: 50 and 100 μM, for 48 hours incubations. 
Interpretation of the data was carried out after unsupervised Principal Component 
Analysis (PCA) of the spectra (vector normalised and mean centred). 
Knowing that the Raman spectrum of a cell represents its chemical fingerprint, 
particular attention was paid to the bands from the main cellular components: Protein – 
Amide I at 1660 cm-1 and Amide III at 1250 cm-1; Lipids – CH/CH2 deformation modes 
around 1450 cm-1; DNA and RNA – phosphate stretching at 1172 cm-1, backbone modes 
at 950 to 810 cm-1, and purine and pyrimidine residues at 800 to 650 cm-1; phenylalanine 
at 1000 cm-1. 
4.1.5.1. p-coumaric acid 
For MDA-MB-231, assessment of the spectra of p-Ca-treated cells against the 
control did not yielded a clear differentiation between either concentration or cell type 
(Figure 31), suggesting that this compound does not interfere significantly with particular 
cellular components. Actually, the results obtained by the MTT and SRB assays showed 
that this phenolic acid, at high concentrations (50 and 100 M), increases cell viability 
without affecting the cell´s protein content. This behaviour can be related with a pro-
oxidant effect in the cancer cells. 
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Figure 32 – Average Raman spectra (A) and PCA score plots (B) for p-Ca-treated MDA-MB-231 cells vs 
control (50 and 100 μM, 48 hours exposure). 
The Raman data and corresponding PCA analysis for the MDA-MB-231 cells 
incubated (for 48 hours) with p-Ca-7.5 and 15 μM are comprised in Figure 33, and reflect 
a quite different behaviour. The PC1 score plot carries enough variance to distinguish the 
sample group from the control, while the PC2 score plot differentiates between p-Ca 
concentrations (Figure 33 (C)). A close PC1 inspection reveals a more significant impact on 
proteins (Amides I and III at 1660 and 1250 cm-1), DNA/RNA (phosphate stretch at 1170 
cm-1) and phenylalanine (1000 cm-1). In turn, PC2 exposes interference on lipids (1450 cm-
1) and DNA/RNA (1170 and 750-700 cm-1) (Figure 33 (C)). 
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Figure 33 – Average Raman and Difference spectra (A), and PCA score (B) and loading (C) plots for p-Ca-
treated MDA-MB-231 cells vs control (7.5 and 15 μM, 48 hours exposure). 
These microRaman results evidence an interference of p-Ca preferentially with 
proteins, lipids and DNA/RNA. Since the MTT results previously discussed for this 
compound (section 4.1.2.1.) unveiled a chemoprotective effect (at low concentrations, 
below 15 μM), it is presently suggested that p-coumaric acid interacts with lipids within 
the cell, stabilising membranes and shielding against cell damage, in agreement with 
published studies on this phenol´s capacity to reduce lipid peroxidation and avoid altered 
membrane fluidity and permeability [166-168]. The compounds nitrosamine inhibitory 
and ROS scavenging abilities [169-171] may also add to this chemoprotective capacity. 
Additionally, the effects on DNA, RNA and phenylalanine are related to changes in 
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cell proliferation [101] and protein synthesis, in accordance with previous works showing 
that p-Ca can delay cell proliferation by downregulating genes associated with the cell 
cycle [66,172]. 
In turn, the cytotoxic effect of p-Ca at 15 μM, determined by the MTT assay as a 
small one, appears to be significant since the PCA analysis of the microRaman data yiels a 
clear differentiation from the lower concentration and the control (Figure 33). Actually, 
for 15 μM p-Ca can have an opposite effect to the one detected for 7.5 μM, destabilising 
lipid structure and therefore changing membrane fluidity and permeability, which was 
found for another HCAs [64]. 
Furthermore, p-Ca´s impact on proteins (particularly Amide I band) can be related 
to its effect on cell migration (section 4.1.3.) which is associated to activation of particular 
proteins. 
 
Figure 34 – Average Raman spectra (A) and PCA score plots (B) for p-Ca-treated MCF-7 cells vs control (7.5 
and 15 μM, 48 hours exposure). 
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Figure 34 comprises the microRaman spectra of MCF-7 cells upon exposure (48 
hours) to p-Ca-7.5 and 15 μM. PCA analysis of the data did not contain sufficient variance 
to discriminate between the different samples. Since the activity of phenolic acids is 
closely related to their hydrophylic vs hydrophobic properties, it is possible that p-Ca 
could not enter the MCF-7 cells in sufficient amounts, thus justifying the negligible effect 
currently observed in the Raman spectra (in agreement with the MTT and SRB results). In 
fact, the cellular uptake of p-Ca can be related to the glycolipids present in cell membrane, 
and since MDA-MB-231 and MCF-7 cell lines have different glycolipid composition (e.g. 
neutral glycolipids and gangliosides [152] this fact may be responsible for the cell 
selectivity reflected in the experimental results (MDA-MB-231 vs MCF-7). 
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4.1.5.2. Daidzein 
 
Figure 35 – Average Raman spectra (A), and PCA score (B) and loading (C) plots for DA-treated MCF-7 
cells vs control (50 and 100 μM, 48 hours exposure). 
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Figure 36 – Average Raman spectra (A), and PCA score (B) and loading (C) plots for DA-treated MDA-MB-
231 cells vs control (100 μM, 48 hours exposure). 
For the estrogen-independent cell line (MDA-MB-231), the spectra from the control 
and DA-treated cells are clearly different, and the PCA analysis allows a differentiation of 
the samples (control and 100 μM) (Figure 36). The loading scores reflect the isoflavone´s 
interference with proteins (Amide I band at 1660 cm-1), DNA/RNA backbone (1170 cm-1) 
and phenylalanine (1000 cm-1), which are cellular components associated with cell 
proliferation [101] and protein synthesis (corroborating the decreased cell viability and 
density obtained by the MTT and SRB assays). In view of previous studies in other cell 
lines, evidencing a DA-induced apoptosis via a mitochondrial pathway [173], a similar 
mechanism is presently suggested for the impact of daidzein on MDA-MB-231 cells. 
In turn, for MCF-7 differentiation of the data is only possible for the highest 
concentration (100 M) (Figure 35). Since MCF-7 is an estrogen-dependent cell line the 
4. Results and Discussion 
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main mechanism of action of daidzein and similar compounds can be the regulation of 
estrogen receptors. A reported study on DA-treated MCF-7 cells unveiled an induced 
apoptosis by cell cycle arrest in the G1 and G2/M phases, coupled to an accumulation of 
cells in sub-G0 phase [174]. Additionally, DA may have a role in manganese superoxide 
dismutase (MnSOD) overexpression leading to a decreased cell proliferation and an 
enhanced stress resistance [78], which are associated with ERα (estrogen receptor 
superfamily) that regulate cell growth and differentiation [155]. 
The mechanism of action of daidzein is therefore different in both cell lines tested 
(either estrogen-dependent or independent). Since DA is a powerful antioxidant, it can 
interfere with increased ROS/RNS cell levels leading to mitochondrial dysfunction. Also, 
the visible effect of DA on the phenylalanine band for the MDA-MB-231 cells (PC1 loading 
plot, Figure 36) may be a consequence of affected amino acid synthesis, which leads to 
reduced cell-viability and migration ability (in agreement with migration assays, section 
4.1.3.)
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The dietary phytochemicals currently investigated showed to have a significant 
chemopreventive activity (and even, under certain conditions, an antitumour effect), by 
interacting in different ways with the human breast cell lines tested (both non-neoplastic 
and neoplastic/estrogen-dependent and independent). p-coumaric acid appears to affect 
mostly the lipids, and since these are the most susceptible cellular components to 
undergo oxidation [21] this phenolic acid (at low concentrations, 5-7.5 μM) may be a 
promising chemoprotective agent towards ROS-induced lipid (and membrane) damage. 
Daidzein, in turn, will be a more powerful chemoprotective agent in hormone-dependent 
cells as compared to hormone-independent ones. 
The ROS/RNS quantification assay currently performed corroborate these 
conclusions, and show a marked cell selectivity for the two tested phytochemicals. 
The high sensitivity of the Raman microspectroscopy technique (coupled to a 
dedicated multivariate analysis of the data) allowed to unveil the impact of the 
compounds under study at the cellular level, by monitoring the biochemical profile of the 
cells in their presence (as a function of concentration), the lipid and protein components 
being the most affected. 
Overall, there is a clear discrimination between both concentration ranges (7.5/15 
M and 50/100 M) regarding the compounds´ effect on the breast cancer cells Figure 
37.  
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Figure 37 – PCA score plots for p-Ca-treated MDA-MB-231 cells vs control (7.5, 15, 50 and 100 μM, 48 
hours exposure). 
Also, it is evident from the results that for the highest concentration tested (100 
M) both phytochemicals behave differently as compared to the lower dosages, which 
should reflect a different mechanism of action still to be clarified by further studies. 
Phytochemical compounds are the subject of an increasing research effort towards 
the development of natural-based chemopreventive agents, as well as of alternatives to 
chemically designed antineoplastic agents either as constituents of chemotherapeutic 
drug combinations or as adjuvants. Indeed, the costs associated with the extraction and 
purification of phytochemicals from their natural sources (fruits and vegetables) might 
well be lower than those involving the rational design of new chemical entities aimed as 
chemopreventives and/or drugs [175]. Additionally, the use of p-Ca and DA in adjuvant 
therapy (mostly when coupled to a suitable delivery system) may help to reduce 
deleterious side effects and acquired resistance, leading to an enhanced patient 
compliance and a brighter chemotherapy outcome.  
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The work presently reported should be extended to other dietary polyphenolic 
compounds as well as to different cell lines (namely distinct types of human cancers, 
preferably those with a poor prognosis). Currently, sufficient data has been collected to 
allow further evaluation of the use of phytochemicals as adjuvants, in combination with 
conventional chemotherapeutic drugs (such as Tamoxifen or Docetaxel in the case of 
breast cancer). Additionally, assessing the effect of combinations of p-Ca and DA, at 
different concetrations and incubation times, could yield interesting results, mainly if a 
synergetic effect regarding chemoprevetive potency can be unveiled. 
Establishment of oxidative stress conditions followed by measurement of the 
intracellular ROS levels, in the absence and presence of the phytochemical agents (both 
in sole administration and in combination), would also yield important clues as to their 
preventive efficiency towards oxidative-induced carcinogenesis. 
Another relevant experiment would be the in vitro wound-healing assay, to 
complement the cell migration data already gathered for the isolated p-Ca and DA. 
Coupled to anti-angiogenic evaluation tests, this would allow to attain a complete picture 
of the phenolic agents´ effect on cell invasiveness and metastatic ability. 
Studies in 3D co-cultures are also a natural continuation of the present work, 
allowing to extend the conventional 2D biological model to a more realistic one, closer to 
the in vivo tissue morphology and function. 
Regarding state-of-the-art microvibrational techniques (particularly Raman), 
optimisation of the experimental conditions for the specific models under study is 
essential for a full use of the extraordinary potential of such methods in probing the 
impact of exogenous agents on the cellular environment. Surface-Enhanced Raman 
Spectroscopy (SERS) can also be of use in this type of study, particularly for monitoring 
specific organelles within the cell. Finally, it would be ideal to be able to take profit of the 
brilliance of the synchrotron radiation in microFTIR measurements (complementary to the 
microRaman ones). 
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